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Choosing an MD/MPH
A NOTE FROM ROSS HALL
D
ear Colleagues,
The decision by George Washington University 
(GW) President Thomas LeBlanc to name Barbara 
Lee Bass, MD, RESD ’86, the new vice president for 
health affairs (VPHA) and dean of the School of Medicine 
and Health Sciences (SMHS) was greeted with enthusiasm 
by faculty, students, residents, staff, and alumni. Former 
president of the American College of Surgeons and chair of 
the Department of Surgery at Houston Methodist Hospital, 
Dr. Bass has established herself as one of the nation’s leading 
academic surgeons. As a graduate of the GW surgery residency 
program and a former member of the GW surgery department, 
Dr. Bass is well-liked and highly respected by her faculty peers. 
She is remembered very fondly by the alumni whom I spoke 
with at the recent GW MD Alumni Reunion Weekend and 
who rotated on her team during their surgery clerkships. I 
also listened to many of the graduates thank her for her superb 
remarks at the 2019 MD Diploma Ceremony as they crossed 
the stage, accepted their diplomas from me, and shook her 
hand. Standing next to Dr. Bass on the stage at the ceremony, 
I noticed that she managed to maintain her broad smile 
without showing any signs of fatigue while congratulating 
each of the graduates. I believe that this was good preparation 
for becoming the next dean. She will be joining GW on Jan. 
15, 2020, and I will continue to serve in the VPHA and dean 
positions until she arrives. Dr. Bass and I have already begun 
working on the transition, and I look forward to continuing to 
be available to her as she requests.
Speaking of our recent MD Alumni Reunion Weekend, 
I was thrilled that we had the largest turnout for the annual 
event. It was a special reunion for me because it was my last 
one as dean, and I will miss engaging with my fellow alumni 
(many of whom I taught along the way). In a moving ceremony 
held in GW’s Corcoran School of the Arts and Design, we also 
unveiled the official portrait of another GW alumnus who 
served as VPHA and dean, John F. “Skip” Williams Jr., MD 
’79, EdD ’96, RESD ’83, MPH, who graduated from the MD 
program and the anesthesiology and critical care medicine 
residency. Skip’s classmates from the MD Class of 1979 turned 
out in force and, as a class, had the highest percentage of donors 
as well as the highest total giving for their alumni class gift. 
Congratulations to Skip and the MD Class of 1979!
As I wrap up my final column in Medicine + Health, I 
want to thank Executive Editor Anne Banner, Managing 
Editor Thomas Kohout, Associate Editor Katherine Dvorak, 
Assistant Editor Ashley Rizzardo, and all the writers, 
photographers, and illustrators who create this award-winning 
magazine. My goal with Medicine + Health was to engage the 
reader and expand our outreach to alumni and friends. We’ve 
worked to show who we are as a school by presenting stories 
that demonstrate the breadth of the many exciting things 
happening at GW SMHS; providing insights into our amazing 
students, staff, faculty, and alumni; and always trying to 
reflect the powerful diversity of our community. Everything 
in this magazine ultimately ties back to our noble mission 
of education, advancing knowledge, and healing, as well as 
promoting a culture of excellence through inclusion, service, 
and advocacy to improve the health of our local, national, and 
global communities. This mission was my guiding star every 
day in this job as VPHA and dean. I am incredibly grateful and 
humbled to have had the opportunity to lead this great school 
in support of our collective efforts to enrich and improve the 
lives of those we serve. Thank you for your incredible support 
over the past nine years, and best wishes to Dr. Bass as she 
embarks on this exciting new chapter.
JEFFREY S. AKMAN, MD ’81, RESD ’85
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Graduates Look  
to Bright Future
Over the weekend of May 18, hundreds 
of the George Washington University 
(GW) School of Medicine and Health 
Sciences (SMHS) graduates crossed 
the stage in Lisner Auditorium before 
cheering crowds of friends and fami-
lies, taking the next step toward their 
future successes.
Health sciences program students 
received their diplomas on Saturday, 
hearing words of wisdom from Reamer L. 
Bushardt, PharmD, PA-C, senior asso-
ciate dean for health sciences at SMHS, 
and many of their fellow graduates. 
The following day, it was the medical 
students’ turn, whose keynote speaker, 
Barbara Lee Bass, MD, RESD ’86, will take 
over as dean of SMHS in January 2020.
“I know there were times when 
you felt like this was a tough path you 
had chosen,” Bass told the graduates. 
“But be sure, you have chosen a great 
path for a life’s mission and just passed 
another great milestone.”
GW, Hoth Therapeutics 
Sign Sponsored 
Research Agreement
Biopharmaceutical company Hoth 
Therapeutics, Inc., which is focused 
on unique targeted therapeutics for 
patients suffering from conditions such 
as atopic dermatitis, has entered into 
a sponsored research agreement with 
the George Washington University 
(GW) to explore the use of Aprepitant 
for topical and/or systemic therapy to 
counter the dermatological related 
side-effects of Erlotinib therapy in 
cancer patients.
Erlotinib is a drug that is used to 
combat various cancers and has been 
known to cause varying degrees of 
skin rashes, lesions, hair loss, and nail 
changes in patients. The side effects 
can impact a patient’s quality of life 
and even cause treatment interruption, 
jeopardizing the overall success of 
the therapy.
The research agreement intends 
to explore whether other chronic 
conditions that also display derma-
titis may benefit from this novel 
therapeutic approach. Overseeing the 
collaboration is William B. Weglicki, 
MD, professor of biochemistry and 
molecular medicine and professor of 
medicine at the GW School of Medicine 
and Health Sciences. 
In his charge to the health sciences 
graduates, Bushardt told them to be 
responsible for their own learning and 
personal growth. 
“Learn to harness that knowledge 
and recognize your limitations. Embrace 
uncertainty and ambiguity in your 
careers. Serve the community around 
you; see what’s missing and provide 
it, see what’s inadequate and provide 
it, see what works and embrace it,” he 
said. “Choose the path of leadership, 
and lead with the character and values 
you have lived here at GW.” 
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MD Student Selected for 
NIH Medical Research 
Scholars Program
Dara Baker, third-year MD student at 
the George Washington University 
School of Medicine and Health 
Sciences (SMHS), was named as 
a fellow in the National Institutes 
of Health’s (NIH) 2019–20 Medical 
Research Scholars Program.
Baker is one of only 50 students 
chosen for the prestigious research 
training program, which allows 
students to take a year off from univer-
sity studies to conduct basic, clinical, 
or translational research on the NIH 
campus in Bethesda, Maryland. 
During her research year, Baker is 
working in the National Eye Institute at 
NIH. Observing an eye surgery in her 
third year at SMHS really piqued her 
interest in the field, she said.
“What I love about the research 
in this field is its investigation in both 
local and systemic pathways of disease. 
Ophthalmology research encompasses 
molecular biology, bioinformatics, 
technology, biophysics, and many 
other overlapping fields of interest for 
me,” she said. 
GW Launches Doctor of 
Health Sciences Program 
in Leadership in Clinical 
Practice and Education
A new Doctor of Health Sciences 
Program in Leadership in Clinical 
Practice and Education offered by 
the George Washington University 
School of Medicine and Health 
Sciences (SMHS) promises to enhance 
competencies and leadership skills in 
both education and clinical practice.
The program “addresses the 
complexity of the current practice 
environment, as well as the need for 
increased credentialing of health 
care educators,” said Joyce Maring, 
EdD, DPT, program director and 
chair and associate professor in 
the Department of Health, Human 
Function, and Rehabilitation Sciences 
at SMHS. 
The program prepares profes-
sionals from a range of practice areas 
who seek to build competencies in 
advanced professional leadership, 
whether that be in the clinical or 
academic environment. 
White Coat Welcome
New students in the George Washington 
University School of Medicine and 
Health Sciences streamed onto 
campus over the summer to continue 
on the path to their career aspira-
tions. GW welcomed the new 
classes to the MD program, health 
sciences programs, residency 
programs, and the Institute for 
Biomedical Sciences with 
white coat ceremonies, 
orientation activities, and 
service projects. 
SMHS Received 2019 
Partnership Award from 
Virginia DOE 
The George Washington University 
(GW) School of Medicine and Health 
Sciences (SMHS) was selected by the 
Commonwealth of Virginia Department 
of Education (DOE) as a recipient of the 
2019 Creating Excellence Business & 
Industry Partnership Award for Region 4. 
The awards are presented annu-
ally to recognize exemplary programs 
and partnerships that promote excel-
lence in career and technical education. 
SMHS was nominated for this award 
by the Alexandria City Public Schools 
for their partnership on the Health 
Sciences Academy at T.C. Williams 
High School, which was endorsed by 
the Commonwealth of Virginia as a 
Governor’s Academy. 
The program prepares students 
for targeted careers, raising student 
aspirations, attracting more students to 
postsecondary education in prepara-
tion for technical careers, and meeting 
the workforce needs of existing busi-
ness and industry. 
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GW Launches 
Correctional Health 
Administration 
Degree Program
The George Washington University 
(GW) is offering a first-of-its-kind 
online Master of Science in Health 
Sciences (MSHS) in Correctional 
Health Administration. This program is 
designed to prepare graduates to lead 
health care initiatives for incarcerated 
populations in U.S. jails or prisons.
Newton E. Kendig, MD, clinical 
professor of medicine at the GW School 
of Medicine and Health Sciences, brings 
25 years of experience as a correctional 
health care administrator to his role 
as program director for the MSHS in 
Correctional Health Administration.
“Serving patients in a correc-
tional facility comes with a unique 
set of challenges,” said Kendig. “Our 
program was carefully designed to 
create health care leaders who know 
how to meet the needs of diverse 
patients while balancing a budget and 
managing a team of correctional health 
care professionals.”
Classes started in fall 2019, with 
the program offering both graduate 
Concentrating 
on Nutrition 
The George Washington University 
School of Medicine and Health 
Sciences has added a nutrition concen-
tration for students enrolled in the 
Master of Science in Health Sciences 
(MSHS) in Integrative Medicine. 
Eating an unhealthy diet is the 
main contributor to the global burden 
of disease, according to the World 
Health Organization. Nutrition is key 
to the prevention of chronic diseases, 
such as diabetes, obesity, and cardio-
vascular disease. However, surveys 
routinely report that these health care 
providers feel unprepared to counsel 
their patients on nutrition. The MSHS 
in Integrative Medicine with a concen-
tration in nutrition was designed to fill 
this knowledge gap and help providers 
and those in health-related profes-
sions obtain mastery of nutrition and 
nutrition counseling.
The course prepares students to 
design and lead outcomes research — 
a critical need for the field. Students 
also have the opportunity to develop 
a business plan focused on delivery of 
integrative medicine and nutrition with 
the help of industry experts. 
GW and Budapest’s Semmelweis University  
Partner on Academic and Research Initiatives 
A new five-year partnership between the George Washington University (GW) 
and Semmelweis University in Budapest, Hungary, will lead to collaborations on 
academic and research initiatives aimed at developing exchange programs and 
interprofessional education for faculty and students at GW.
The goals of the partnership include harmonizing research plans and creating 
joint grant submissions. The collaboration also includes conducting faculty and 
student exchange programs. In addition, GW lecturers will go to Semmelweis 
University to train professors to enhance their performance in online and blended 
education, as well as clinical simulations. GW will also integrate Semmelweis 
University into the GW Collaboratory, which is a mostly virtual environment where 
stakeholders work and communicate to achieve an understanding of complex 
health-related issues, design innovations and solutions, participate as collabora-
tors, and improve health and health care. 
certificate and master’s degree 
curricula built on serving the unique 
health care needs of incarcerated 
patient populations, improving health 
outcomes, and leading correctional 
health care teams. 
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GW Health Care Quality 
Program Receives 
CAHME Certification
The Health Care Quality Program at 
the George Washington University 
(GW) School of Medicine and 
Health Sciences is among the first 
four programs to receive national 
certification by the Commission 
on Accreditation of Healthcare 
Management Education (CAHME).
Earning the certification is an 
important milestone for the program. 
CAHME is currently developing 
accreditation standards that schools 
can apply for in the coming years. The 
Health Care Quality Program at GW 
was among 10 health care quality and 
safety programs across North America 
chosen to support the effort.
The Health Care Quality Program 
at GW was developed to meet an 
emerging demand for quality and 
patient safety specialists who have the 
capacity and competence to grow and 
sustain a culture of continuous improve-
ment at all levels and within every sector 
of the health care delivery system. 
GW Cancer Center Chosen as First Site 
for Cancer Clinical Trial 
Under the leadership of Vishal A. Patel, MD, director of the 
Cutaneous Oncology Program at the George Washington 
University (GW) Cancer Center, GW was selected as the first 
global site of a clinical trial for patients with high-risk cuta-
neous squamous cell carcinoma. 
The study, sponsored by biotechnology company 
Regeneron in collaboration with multinational pharma-
ceutical firm Sanofi, will compare disease-free survival of 
patients treated with adjuvant cemiplimab, versus those 
treated with placebo after surgery and radiation therapy.
The phase III trial is intended to investigate the drug’s 
safety and effectiveness in preventing recurrence and 
metastasis in high-risk cutaneous squamous cell carcinoma. 
Cemiplimab was approved by the U.S. Food and 
Drug Administration in 2018 to treat patients with meta-
static cutaneous squamous cell carcinoma, or locally 
advanced cutaneous squamous cell carcinoma, who are 
During summer 2019, the George 
Washington University School of 
Medicine and Health Sciences (SMHS) 
joined the American Association of 
Kidney Patients (AAKP) in co-hosting 
the Inaugural Global Innovations in 
Patient-Centered Kidney Care Summit. 
Summit organizers sought to put 
policy insight in the context of science 
and innovative practical solutions, 
identify challenges, discuss solutions, 
not candidates for curative surgery or curative radiation. 
The immunotherapy treatment is a fully human, monoclonal 
antibody targeting the immune checkpoint receptor PD-1 
(programmed cell death protein-1) and was the first treat-
ment approved and available for advanced cutaneous 
squamous cell carcinoma in the United States. 
and identify the research needed to 
inform and evaluate policies to improve 
kidney health.
There are more than 815 million 
people with chronic kidney disease 
around the world, said Dominic Raj, MD, 
chief of the Division of Kidney Diseases 
and Hypertension and professor of 
medicine at SMHS, who helped put 
together the three-day conference. 
Exploring Innovative Patient-Centered Kidney Care 
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The 2019 GW Legacy Challenge provides an immediate cash match for donors who document new or increased 
planned gift commitments to the School of Medicine and Health Sciences, such as gifts by will, trust, or IRA 
beneficiary designation. As a planned giving donor, you can direct matching funds to your area of interest (equal to 
10% of the value of your planned gift, up to $10,000).
The GW Legacy Challenge will end on either December 31 or when the unrestricted matching funds have been 
depleted, whichever comes first. More than half of the matching funds have already been distributed, so don’t wait 
to make an immediate impact.
10% Legacy Challenge 
Match Funds are directed 
where you specify
Future impact with 
your planned gift
+ x=
You document your planned 
gift using the Legacy Challenge 
Gift Confirmation Form
Immediate impact 
to your area of 
interest at GW
Visit go.gwu.edu/give110Med to learn more.
Participate in the 2019 GW Legacy Challenge and give 110% to GW!
DAR3682
With his formal installation as the inau-
gural Dr. Cyrus Katzen Family Director 
of the George Washington University 
(GW) Cancer Center, Eduardo M. 
Sotomayor, MD, joined an elite group 
of endowed professors, chairs, and 
directors throughout the GW School of 
Medicine and Health Sciences. 
“I am truly honored and humbled 
to serve as the inaugural Dr. Cyrus 
Katzen Family Director,” Sotomayor 
said. The recognition, he added, “is an 
acknowledgement of the many people 
who influenced and guided me along 
an exciting journey that took a boy from 
a small town along the coast of Peru to 
America, the greatest country, which 
adopted me and allowed me to fulfill 
my personal and professional dreams.”
Sotomayor, a research leader in 
the study of immunotherapy of B-cell 
malignancies, came to GW just four 
years ago to serve as the director of 
the GW Cancer Center. In those years, 
Sotomayor has unified GW’s cancer 
research and clinical care, by advancing 
research innovation, personalizing 
cancer care, and supporting cancer 
policy development. His overarching 
goal for the GW Cancer Center is to 
earn designation as a National Cancer 
Institute comprehensive cancer center. 
“We’re here to continue to build 
upon the important legacy my father, 
Dr. Cy Katzen, has established here 
at GW and in the Washington, D.C., 
region in the area of cancer research 
and patient-related cancer care,” said 
Jay Katzen, MD ’72, BA ’67. The two-
time GW alumnus and director of the 
Cyrus Katzen Foundation recalled his 
family’s extensive ties to GW. 
The Katzen family’s support 
over the past two decades has been 
critical to cancer care at GW and in 
Washington, D.C. In 2008, Cyrus and 
Myrtle Katzen made a $10 million gift 
to establish The Dr. Cyrus and Myrtle 
Katzen Cancer Research Center. 
The directorship will support basic 
science and translational research, 
new treatment protocols, academic 
needs for medical students and clini-
cians, honoraria for visiting scholars, 
pilot research grants for residents and 
fellows, and equipment needs. 
Eduardo M. Sotomayor, MD, Installed  
as Inaugural Dr. Cyrus Katzen Family Director
Agree to Lead Fundraising  
for GW Clinical Enterprise 
George Washington University (GW) selected 
Jonathan Agree to serve as the new associate 
vice president of health and medicine. 
Agree joined GW from the Sidney Kimmel 
Cancer Center and Clinical Programs at Thomas 
Jefferson University Hospitals, where he was vice 
president of development. In this role, Agree 
oversaw a team that raised more than $85 million. 
Most recently, he closed the second largest gift 
to the cancer center supporting the launch of the 
Philadelphia Prostate Cancer Biome Project. 
In his role at GW, Agree oversees the fund-
raising teams for the health and medicine enterprises at GW, including the School 
of Medicine and Health Sciences, the School of Nursing, the GW Medical Faculty 
Associates, and the Milken Institute School of Public Health at GW. 
The George Washington University 
(GW) has sold a portion of its royalty 
rights for a drug originally developed 
at the School of Medicine and Health 
Sciences (SMHS), officials announced 
in August 2019. The move allows GW to 
reinvest significant funds into strategic 
priorities in academics, research, and 
innovation, accelerating its growth as a 
preeminent research university.
The first and only FDA-approved 
drug of its kind, GIAPREZA™ is used to 
increase dangerously low blood pres-
sure in life-threatening situations and 
has the potential to benefit hundreds of 
thousands of patients each year in the 
United States.
“This is an extraordinary example 
of GW research and innovation at 
its best,” said GW President Thomas 
LeBlanc. “A treatment developed here 
will improve clinical care and save 
lives, while at the same time provide 
resources for our university to reinvest 
in research for the next big discovery. 
Our impact on society will only 
continue to grow.”
Rodham Institute 
Celebrates Art of 
Medicine and Science
For most people, the link between the 
arts and health is a crooked line, but 
take a closer look and you can find 
many examples of the arts playing a 
role in health and well-being. This idea, 
“Incorporating the Arts to Improve the 
Health and Wellbeing of Washington, 
D.C.,” is what brought out community 
leaders and clinicians to the 6th Annual 
Rodham Institute Summit.
“One of the reasons we decided 
to choose ‘Incorporating the Arts to 
Improve the Health and Wellbeing 
of Washington, D.C.’ as the theme 
of this year’s summit is that the arts 
have really been the glue that binds 
our society together. The arts are 
really who we are as human beings,” 
explained Jehan “Gigi” El-Bayoumi, 
MD, RESD ’88, professor of medicine 
at the George Washington University 
School of Medicine and Health 
Sciences and founding director of the 
Rodham Institute.
The 2019 event was held in the 
Southeast Tennis and Learning Center 
and live-streamed by online health 
resource publication BlackDoctor.org. 
More than a dozen members of local 
organizations kicked off the daylong 
summit, with each giving brief presen-
tations or performances on how they 
are incorporating music, dance, art, 
and storytelling into their community 
health and engagement efforts. 
The development of GIAPREZA™ 
began several years ago. With funding 
from the university, a team at SMHS 
conducted a clinical trial at GW testing 
the effectiveness of a peptide hormone, 
angiotensin II, on blood pressure. 
In 2014, the university entered 
into a license agreement with La Jolla 
Pharmaceutical Company for GW’s 
intellectual property rights, allowing the 
company to complete the FDA approval 
process and bring the drug to market. 
The FDA approved GIAPREZA™ in 2017.
The university and faculty, through 
GW’s Technology Commercialization 
Office (TCO), often work together 
to bring research to market. TCO 
helps researchers secure intellec-
tual property licenses, patents and 
technology commercialization part-
nerships, among other assistance. 
Over the past five years, patents filed 
on GW inventions have doubled, 
GW-licensed startups secured more 
than $200 million in outside funding, 
and licensing income to GW has 
increased dramatically. 
Return on Investment to Accelerate Research Growth
 GWMEDICINEHEALTH.COM 7
A home is often defined simply as a place where one lives, but for Esosa Imasuen, MD, the word paints a more diverse picture. For her, home is the people, cultures, and experiences that have 
shaped her and led her to where she is today: in residency at 
the George Washington University (GW).
Imasuen, a third-year internal medicine resident at the 
GW School of Medicine and Health Sciences, sees a home in 
her birthplace, the United States, and in Nigeria, where she 
spent her early years — and wants to ensure her work spans 
the miles between those countries.
“I’ve spent about equal amounts of time in the United 
States and in Nigeria. My childhood memories are in Nigeria, 
and thanks to my mother I had a great childhood. I am 
very fond of Nigerian music and food, and the resilient and 
creative nature of the people. Nigeria is very vibrant, albeit 
chaotic, and there’s just something about it that’s special,” she 
says. “And when I am here in the United States, I am equally 
at home too.”
So far in her residency at GW, Imasuen says even when 
the work gets tough, she remembers the impact she’s making 
on patients’ lives and leans on the support of her program 
mentors and colleagues to motivate her to keep going.
“I am so blessed to be in this program because I feel at 
home here. I’ve been able to make good friends, and whenever 
I am struggling there’s always someone to help me. It really is 
a family,” she says. “It is exactly what we were told to look for 
in a residency, and I am lucky to have found that.”
She adds that she’s also happy to be closer to Maryland, 
where she was raised and where her “always supportive” 
mother and aunts still live.
Although Imasuen has decided to practice primarily in 
the States, she wants to make an impact on how primary care 
works in Nigeria as well, especially through improvements 
to the continuity of care offered there. Nigeria’s primary 
care system is different from America’s; the average Nigerian 
patient does not see the same provider from year to year, and 
might not even go to the same practice each year. Because of 
that, Nigerians typically do not have one designated provider 
who knows their medical history. Imasuen says she wants to 
improve that.
“Last year, through the aid of the Global Health Elective 
Grant, I was able to return for a second rotation at a Nigerian 
hospital in Lagos. On these trips, I take a little black book in 
which I write down areas [in which] I could help with quality 
improvement or things I can do to advance the system. I also 
jot down pearls of wisdom I have learned from patients,” she 
says. “I am still trying to figure out my specific role, but I have 
an idea of where I can fit in.”
Imasuen adds that she has always believed in diversity “in 
many shapes and forms.”
“Being able to take different things from different 
cultures has always been something my mom raised me to do, 
which has also enhanced the way I practice medicine,” she 
says. “So I am not surprised at my desire to practice both in 
Nigeria and in the United States.” 
There’s  
No Place  
Like Home
Resident Esosa Imasuen, MD, Says 
Her Career Was Molded by the 
Places She’s Lived and Worked
BY KATHERINE DVORAK
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H
IV/AIDS currently affects nearly 38 million 
people worldwide according to the World 
Health Organization. Infection with HIV 
is associated with a wide range of long-term 
health complications, including the development of cancer, 
which is a major cause of death among individuals living with 
HIV. The AIDS and Cancer Specimen Resource (ACSR), the 
largest collection of annotated HIV malignancy specimens 
globally available to researchers, has received renewed grant 
funding, with the George Washington University (GW) 
serving as the primary site for the next five years. The renewal 
comes following a $22 million grant from the National 
Institutes of Health. 
The ACSR was established in 1994 through a cooperative 
agreement with the National Cancer Institute (NCI) and is 
overseen by principal investigators from the two legacy sites, 
GW and the University of California, San Francisco. The 
ACSR also includes consortia at Baylor Medical College; 
Mayo Clinic in Scottsdale, Arizona; and Stellenbosch 
University in Cape Town, South Africa.
“Through this grant, we are working to acquire, store, 
and equitably distribute tumor tissues and biological fluids 
from individuals 
with HIV-associated 
malignancies to meet 
the biospecimen needs 
of researchers studying 
HIV-associated 
malignancies,” says 
Sylvia Silver, DA, 
director of the 
GW Biorepository 
and professor of 
microbiology, 
immunology, and 
tropical medicine at the 
GW School of Medicine 
and Health Sciences.
BY ASHLEY RIZZARDO
As part of the award, Silver, one of the principal 
investigators on the project, will serve as the director of 
the AIDS Malignancy Clinical Trials Consortium (AMC) 
Biorepositories. The AMC, which is funded by the NCI, 
engages more than 250 clinicians and conducts clinical trials 
in the United States, sub-Saharan Africa, and Latin America. 
Currently, the AMC biorepositories are located at GW for U.S. 
domestic trials and at Stellenbosch University for African trials.
During the grant cycle, Silver will assist NCI in the 
selection of a new ACSR site in Latin America to support 
AMC clinical trials in the region. In early 2014, Silver worked 
closely with her South African counterparts to provide 
quality management expertise and advice on best practices as 
Stellenbosch University prepared to launch the sub-Saharan 
African biorepository.
The GW Biorepository has served as a comprehensive, 
state-of-the-art resource for biospecimen processing, 
storage, and disbursement, designed to help today’s leading 
investigators facilitate their research. This year, the GW 
Biorepository earned designation as a core facility and 
accreditation by the College of American Pathologists.
The GW Biorepository is one of seven core facilities 
— along with the Biostatistics Center, Flow Cytometry 
Core Facility, GW Biomarker Discovery and Analysis Core 
Facility, McCormick Genomic and Proteomic Center, 
Nanofabrication and Imaging Center, and the Research 
Pathology Core Lab — throughout GW that offers a range of 
services, including cutting-edge technologies and high-end 
instrumentation coupled with research technical support for 
university investigators. 
Bio Banking
Major NIH Grant Sustains 
the Largest HIV Malignancy 
Specimen Bank
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HEALTHY JOBS
GW Health Sciences Provides Critical 
Skills for Successful Careers
H
ealth care is a constantly changing industry, and many 
advances are moving the field in directions previ-
ously unimagined. Amid these changes, the George 
Washington University (GW) School of Medicine and 
Health Sciences (SMHS) is focusing on filling workforce gaps 
and helping health care professionals develop skills that will 
drive their organization forward and continuously improve 
health care.
“We are constantly responding to the workforce needs 
and addressing gaps in health care and translational science 
fields,” says Reamer Bushardt, PharmD, PA-C, senior 
associate dean for health sciences at SMHS. “GW is a global 
leader in training health and research professionals who are on 
the cutting edge of their disciplines.”
GW’s health sciences, a vibrant division within SMHS, 
is well known for the academic programs it offers to students 
interested in becoming physician assistants (PAs), biomedical 
laboratory scientists, and physical therapists, but a wide array 
of additional programs within the division focus on giving 
working professionals a stronger skill set and the specialty 
training they need to advance in their career and evolve with 
the health care industry.
Bushardt says health sciences faculty and staff work 
closely with national professional associations and large 
health care employers, the types of organizations that best 
understand current and evolving workforce needs. 
One such group SMHS has a close relationship with 
is the American Academy of Physician Assistants (AAPA). 
Through the AAPA Center for Healthcare Leadership and 
Management (CHLM) Degree Pathways Program, SMHS is 
able to help PAs advance their careers with programs offered 
at discounted rates in clinical operations and management, 
clinical and translational research, health care quality, and 
integrative medicine. SMHS faculty members also regularly 
collaborate with regional government officials and economic 
development agencies to understand workforce priorities and 
skill gaps in the community. 
“Developing different trajectories for a profession, or 
building on the future of health care professions, can help 
practitioners get ahead of the curve and understand where 
the industry is going,” says Leslie Davidson, PhD, chair of the 
Department of Clinical Research and Leadership and associate 
professor of clinical research and leadership at SMHS.
Davidson says any organization should have workforce 
development as a top priority, but especially universities. 
“With technology advancing so rapidly, and with the need for 
big data and analysis of information, there’s a different type of 
worker needed with a different type of skill set. Universities 
can ensure these competencies are achieved — and we are 
primed here at GW to do that.”
In the programs offered at SMHS, health professionals 
can make as big or as little a commitment to their 
development as they want. They can do something as simple 
as listen to a podcast, attend a webinar, or take part in a 
workshop, or take the bigger step of earning a certificate or 
participating in a master’s or doctoral program. 
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These kinds of offerings don’t just give people in the 
health care workforce the tools to move forward in their 
career, Davidson says, they’re also essential in making sure 
the industry can meet the needs of its community locally, 
nationally, and globally. “To have different stakeholders all 
have their hand in the development process is really critical 
for it to be successful,” she says, “and we are committed to this 
approach for developing curricula at GW.”
SMHS faculty in the health sciences are also involved in 
workforce development programming through the Clinical and 
Translational Science Institute at Children’s National (CTSI-
CN). The CTSI-CN was established through the Clinical and 
Translational Science Award, given to 60 major U.S. research 
institutions by the National Institutes of Health (NIH). GW 
and Children’s National originally earned the award in 2010, 
and in 2016 the partners received a five-year extension.
Translational workforce development is a vital area in the 
partnership, which has included creating workshops, courses, 
programs, individualized career development activities, 
and other on-demand training to support the clinical and 
translational workforce. 
“Many individuals within our community must come 
together to accelerate clinical and translational science, 
including scientific investigators, research staff, trainees, 
regulators, and the public,” says Bushardt, who also serves as 
director of translational workforce development for the CTSI-
CN. “Our translational workforce development programs 
bring these individuals together, support their development 
into teams, and provide the necessary skills to translate 
knowledge into interventions and health services that make a 
positive difference in the lives of patients and families.” 
An area of interest that students, clinicians, researchers, 
and fellows want addressed in their training is biostatistics 
and bioinformatics. They are interested in obtaining hands-on 
approaches to analyzing data, says Samar Nasser, PhD, MPH, 
PA-C, associate professor of clinical research and leadership 
and director of the Clinical and Translational Research 
Program. To meet that need, workshops were designed and 
implemented with subject matter experts in biostatistics, 
health informatics, and artificial intelligence.
“We held these workshops either at Gelman or 
Himmelfarb Library, and we’d show the trainees how to 
analyze their data with the help of statisticians from GW and 
Children’s National. In the morning, attendees learned how to 
input their data into an analysis program and by the afternoon 
were actually running their data and analyzing the results,” 
Nasser says. By the end of the day, she adds, attendees were 
able to go back to their offices and know how to analyze their 
data on their own to move their research projects forward.
Another workshop focused on informatics and artificial 
intelligence, including how advanced analytical techniques 
can be applied to clinical research. Three informatics 
specialists were called in to help workshop attendees 
apply big data to their work. “These workshops were very 
successful, and students and trainees have asked for more, so 
we’re hoping to do another,” Nasser says. “Considering new 
applications like natural language processing, for example, 
can lead to innovative thinking and help expand the potential 
impact of the research our trainees are conducting.
“We’re all about being hands-on with the training and the 
professional development we provide. We want to make sure 
that it’s translational and can take people to the next level in 
their work,” she explains.
Even at the most basic level, leaders are eyeing the health 
care marketplace and ensuring that when students leave GW 
they are ready to fill current workforce needs. 
“We are rapidly adapting and adopting curriculum and 
program offerings,” Bushardt says, “to ensure our graduates are 
competitive and prepared for a dynamic health care workforce.” 
He adds that, much in line with GW’s new common 
purpose statement — “Only at GW, we are changing the world 
one life at time” — SMHS is changing the world through 
individualized workforce development, one student at a time. 
“ With technology advancing so rapidly, and with 
the need for big data and analysis of information, 
there’s a different type of worker needed with a 
different type of skill set. Universities can ensure 
these competencies are achieved — and we are 
primed here at GW to do that.”
—Leslie Davidson, PhD
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To excel in today’s competitive environment, the pathology department at an academic medical center must be on the cutting edge of clinical care and research, according to Antonia R. Sepulveda, MD, 
PhD, the new chair of the Department of Pathology at the 
George Washington University (GW) School of Medicine and 
Health Sciences (SMHS). “It must distinguish itself through 
innovation, which needs to be powered by a strong research 
program,” she says.
Sepulveda, who comes to GW from Columbia University 
Irving Medical Center in New York, where she served as vice 
chair for translational research and director of the Division 
of Gastrointestinal Pancreas and Liver Pathology in the 
Department of Pathology and Cell Biology, is eager to pair her 
experience and vision for the Department of Pathology with 
GW’s culture of collaboration to establish pathology as a vital 
element of the school’s mission. 
“I want to promote a culture of scholarly achievements 
within the department,” says Sepulveda, who will also serve 
as the Ralph E. Loewy Professor of Oncology at SMHS and 
as chief of pathology service and clinical laboratory director 
at GW Hospital. “My ultimate goal is to elevate the role of 
the department globally and increase its preeminence at the 
national level.”
Sepulveda, an expert in gastrointestinal pathology 
and molecular diagnostic pathology of cancer, plans to 
use her background as a clinician-scientist to inform her 
approach when it comes to the direction of the department. 
“I believe in the synergism between clinical and research 
experiences,” she says. “Clinical observations can inform 
and launch research questions, and in turn the research may 
bring advancement and innovation that can improve disease 
outcomes and the lives of patients.”
Her plans for the department include bringing cutting-
edge genomic and molecular diagnostic services to GW. The 
laboratory will offer innovative genomic testing, such as next-
generation sequencing, to support personalized or precision 
medicine initiatives and novel cancer therapies.
She also wants to lead her team to develop a program 
in digital and computational pathology, which are 
technologies that are revolutionizing and shaping the field 
of pathology, she says. These and other new initiatives in 
pathology at GW will contribute to supporting outstanding 
clinical services and will fuel translational and clinical 
research both within the department and as collaborative 
transdisciplinary research.
Throughout her career, Sepulveda has made a point of 
mentoring young trainees and helping to foster the future of 
the discipline of pathology, having directed gastrointestinal 
pathology and surgical pathology fellowship programs at the 
University of Pittsburgh, the University of Pennsylvania, 
and Columbia University. As a leader in the field, and now 
the head of her own department, she wants to create an 
environment that showcases the many fulfilling opportunities 
for professionals in pathology and laboratory medicine, and to 
encourage medical students to explore the field of pathology.
“It’s very important to me to help the next generation 
of pathologists find their way to a bright future in the field,” 
Sepulveda says. “In the GW pathology department, I hope we 
will inspire our students and trainees to actively contribute 
and ensure the growth and visibility of pathology as a 
discipline and medical specialty.”
BY ASHLEY RIZZARDO
SHAPING  
THE FUTURE
New Chair Antonia R. Sepulveda, MD, PhD,  
Looks to Advance Pathology Through Innovation
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Her own career trajectory, she explains, was influenced 
by working with mentors Janet Butel, PhD, a prominent 
molecular virologist, and Milton Finegold, MD, a national 
figure in the pathology of liver disease, on a project focused on 
liver cancer development. She says their combined mentorship, 
emphasizing the power of molecular studies and pathological 
and morphological observations in human disease, greatly 
influenced her decision to pursue residency training in 
anatomic pathology.
Mentors continued to have a role in Sepulveda’s path as 
she did her PhD work in the laboratory of Michael Lieberman, 
MD, PhD, at Baylor College of Medicine, furthering her 
knowledge of molecular biology in the context of human 
disease. Her work with David Graham, MD, an internationally 
recognized figure in Helicobacter diseases, steered her research 
interest toward gastrointestinal cancers and pre-cancer lesions.
“The field of pathology and laboratory medicine offers 
enormous opportunities to advance our understanding of 
disease processes, namely leveraging molecular analysis tools, 
such as genomics and transcriptomics, ultimately resulting 
in clinically relevant diagnostic, prognostic, and predictive 
biomarkers,” she says. “[For me,] pathology presented a 
fascinating opportunity to learn about biological processes and 
disease in a very visual, sometimes artsy way.
“The specialty of pathology and laboratory medicine is 
highly data driven,” she continues, “with increasing use of 
digital platforms offering a data-rich trove available to be 
mined using computational tools. A number of algorithms 
are being developed for diagnosis and biomarkers that will 
significantly change the way we practice pathology over time.” 
The emerging field of digital and computational pathology 
offers enormous opportunities to apply the latest advances in 
data science and artificial intelligence.
She maintains that while pathology is a specialty within 
medicine, it is itself very subspecialized and can provide for 
many different interests, including tissue-based pathology 
diagnostics, clinical laboratory pathology, direct patient care 
by specialists in apheresis and transfusion medicine, and basic 
translational and clinical research. And, Sepulveda adds, this is 
a vibrant medical specialty in constant evolution. 
“ It’s very important to me to help 
the next generation of pathologists 
find their way to a bright future in 
the field. … I hope we will inspire 
our students and trainees to actively 
contribute and ensure the growth 
and visibility of pathology as a 
discipline and medical specialty.”
            — Antonia R. Sepulveda, MD, PhD
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Taking the Reins
Barbara Lee Bass 
Named Vice President 
for Health Affairs and 
Dean of SMHS
A
s the George Washington University (GW) School 
of Medicine and Health Sciences (SMHS) enters a 
new decade in 2020, it will do so with its first-ever 
female vice president for health affairs and dean at 
the helm.
Barbara Lee Bass, MD, RESD ’86, a widely respected 
academic medicine leader, surgeon, and researcher who 
completed her residency and served on the faculty at GW, 
begins her role leading SMHS on Jan. 15. She will bring 
her pioneering innovation in academic surgery and her 
commitment to teaching the next generation of physicians to 
a place she knows well. 
“I am thrilled to return to GW, where I became a surgeon 
and began my career in academic surgery,” says Bass. “GW 
is an institution made up of individuals committed to doing 
the right thing for patients, always. This focus drives our core 
missions: developing the physicians and health care providers 
and leaders of the future, driving forward in scientific 
discovery with the aim of translation to clinical deliverables, 
and working with energy and passion to improve the health of 
the citizens and communities we serve. 
“I so look forward to joining these committed individuals 
to propel GW as a dynamic future-driven health care system, 
learning continuously from all we do,” she adds.
In her new role, Bass will be responsible for leading 
SMHS’ academic, clinical, and research missions and 
providing strategic direction on all aspects of GW’s medical 
enterprise, including the university’s relationships with the 
GW Medical Faculty Associates and GW Hospital.
Bass previously served as chair of the Department of 
Surgery at Houston Methodist Hospital (HMH) in Houston, 
Texas, and held numerous positions with its affiliated 
universities and institutes. 
“Dr. Bass has shown a remarkable commitment 
to academic medicine and health care throughout her 
accomplished career. She is a devoted physician, educator, and 
researcher with an inspiring vision for the School of Medicine 
and Health Sciences and the university’s medical enterprise,” 
says GW President Thomas LeBlanc. 
Bass started at HMH in 2005. There, she created 
its surgery department from the ground up, recruiting 
internationally acclaimed faculty; building high-quality 
clinical, residency, and fellowship programs; and creating 
robust interdisciplinary research teams. 
Bass also served as chair of the surgery department 
in the Houston Methodist Specialty Physician Group and 
has contributed to the development of the organization’s 
partnership with the hospital system it serves, helping 
align the entities’ academic, clinical, and research missions. 
Most recently, she held the John F. Jr. and Carolyn Bookout 
Distinguished Presidential Chair and was a professor of 
surgery at Weill Cornell Medical College and the Houston 
Methodist Institute for Academic Medicine; adjunct professor 
of surgery at Texas A&M College of Medicine; and full 
member of the Houston Methodist Research Institute.
Completing her residency in general surgery at GW, 
Bass expanded her training with a research fellowship at the 
Walter Reed Army Institute of Research while serving as a 
captain in the U.S. Army Medical Corps, which launched her 
research career. After graduating, she joined the GW faculty 
as a general surgeon and surgeon-scientist at the Washington 
DC Veterans Affairs Medical Center. 
Throughout her career, Bass mentored medical students, 
surgical residents, research fellows, and fellow faculty 
members, and she directly contributed to the training of 
more than 250 surgical residents. At HMH, she developed 
a highly rated clinical rotation for medical students and led 
the creation of Accreditation Council for Graduate Medical 
Education-accredited training programs in general surgery 
and other surgical fellowships.
Although she is proud of the accomplishments and 
contributions of her faculty and residents at HMH, Bass says 
she has been “very gratified” to have served as the founder 
and executive director of the Houston Methodist Institute 
for Technology, Innovation, and Education, a state-of-the-art 
education and research center that has hosted more than 
55,000 health care providers in practice for training courses. 
As a researcher, Bass names her current interests as 
computational surgery, health services research, and outcomes 
sciences and clinical trials in surgical oncology, following two 
decades of bench research in gastrointestinal biology. For more 
than 25 years, her research has been funded by the National 
Institutes of Health (NIH), the National Science Foundation, 
the VA Health Services Research and Development Service 
program, and the European Union, among others. 
She has published more than 170 peer-reviewed 
manuscripts, and numerous monographs, chapters, and books. 
She also served on NIH review boards and on the editorial 
boards of the Annals of Surgery and the Journal of the 
American College of Surgeons. 
This story was originally reported by GW Today.
“ I so look forward to joining these 
committed individuals to propel GW as a 
dynamic future-driven health care system, 
learning continuously from all we do.” 
—Barbara Lee Bass, MD, RESD ’86
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A Broader Perspective 
on Health Care
Dual-Degree  
MD/MPH Program 
Helps Students 
Link Patient Care 
to the Community 
“In the past few years of medical school, 
I’ve definitely learned a lot about how 
to treat your patients when they’re 
with you face to face,” says the George 
Washington University (GW) School of 
Medicine and Health Sciences (SMHS) 
student. “But so much of our lives are 
lived outside those spaces, and I want 
to ensure my patients are healthy when 
they are not in the doctor’s office.”
That’s why Brown chose to get 
not only her MD degree at SMHS, but 
also a master’s degree in public health 
through a revamped dual-degree MD/
MPH program offered by SMHS and 
the Milken Institute School of Public 
Health at GW (Milken SPH). Under the 
recently updated program, students can earn both degrees in 
just five years thanks to public health offerings built into the 
MD curriculum.
Brown has already finished her first three years of medical 
school and now is deep into her public health education. The 
dual-degree program offers students flexibility in how they 
pursue their education. For Brown, the best path was taking 
the summer, fall, and spring semesters between her third and 
fourth years of medical school for the public health classes. 
She’ll then return to medical school with the Class of 2021 to 
finish out her fourth year.
For a long time, GW has offered students the ability 
to get a dual MD/MPH, but changes to the requirements 
for public health degrees about eight years ago made the 
process more difficult, lowering enrollment in the MD/MPH 
program, says Lawrence “Bopper” Deyton, MD ’85, MSPH, 
senior associate dean for clinical public health, Murdock 
BY KATHERINE DVORAK
Head Professor of Medicine and Health Policy, and professor 
of medicine at SMHS.
However, expanded content in public health, population 
health, health system science, and policy as part of the MD 
curriculum allows for cross-crediting with public health 
degree requirements, streamlining the process.
“This applies to any medical discipline a student may 
want to pursue, be it pediatrics, OB-GYN, pathology, or 
surgery. This is for that student who wants to make the 
public health aspects of their scope of practice a prominent 
feature of their career,” Deyton says. “You look at the former 
students who did the combined MD/MPH before, and they 
are clinicians who are out there leading health systems, 
leading hospitals, leading health departments, and doing 
extraordinary research in public health and policy.”
GW medical students receive 15 credits toward an 
MPH based on the expanded public health content. “That 
Inside the walls of a hospital or clinic, physicians only get a glimpse 
of their patients’ lives, and for MD/MPH student Ciara Brown 
that’s not enough. She wants to know about their lives outside the 
four walls, about the world in which they spend their days — the 
relationships between communities and the health of their residents.
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content includes the new Patients, Populations, and Systems 
courses and the clinical public health summit experiences, 
among other offerings, which leaves only 30 credits needed at 
Milken SPH for the MPH, rather than the usual 45 credits,” 
says Karla Bartholomew, PhD, JD, MPH, PA, program and 
development officer for clinical public health and director of 
the dual-degree MD/MPH program. 
If students don’t want to take the full step toward an 
MPH degree, there is also a graduate certificate in public 
health, which offers similar cross-crediting. “While it would 
typically require 15 credits for the certificate, medical students 
receive cross-crediting for five credits, and only need 10 
credits through Milken SPH, which can be completed within 
the four years of the MD program,” says Bartholomew.
Penciling In Another Degree
Megan Fuerst always knew she’d pursue an MPH in addition 
to her MD degree. The only question was, “when?”
“I could have done it before medical school, during 
medical school, or after as part of a residency program. I 
decided I wanted to do it during medical school because I 
really have enjoyed living in Washington, D.C., and I have 
grown to care a lot about public health and community health 
here,” she says. 
Fuerst has worked as a director at the GW Healing 
Clinic, a free clinic run by SMHS students, and has also 
been involved in a program through the American College 
of Obstetricians and Gynecologists teaching sexual health 
to middle and high school students. “I love family planning, 
reproductive health, and women’s health, and so I’m excited to 
have a chance to evaluate the program and evaluate the needs 
here,” she adds.
Fuerst is taking the bulk of her public health classes in 
the fall and spring after having completed some core courses 
during the summer between her first and second years of 
medical school. 
Some students have even opted to take their public health 
courses after their fourth year, says Bartholomew. “This really 
opens the doors to a wide array of career paths for students 
that they might not otherwise have thought possible.”
“ You look at the former students who did the 
combined MD/MPH before, and they are 
clinicians who are out there leading health 
systems, leading hospitals, leading health 
departments, and doing extraordinary 
research in public health and policy.”
—Lawrence “Bopper” Deyton, MD ’85, MSPH
MD students can complete an MPH 
with one additional year of training 
in any of the following residential 
MPH programs:
Community Oriented Primary Care
Environmental Health Science and Policy
Epidemiology
Global Environmental Health
Global Health Epidemiology and Disease 
Control
Global Health Policy
Global Health Program Design, Monitoring, 
and Evaluation
Health Policy
Health Promotion
Maternal and Child Health
Public Health Communication and Marketing
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Putting it in Practice
SMHS alumnus Sunil Budhrani,  MD/MPH ’99, chief 
executive officer of Innovation Health, a health insurance 
plan created through a partnership between Inova and Aetna, 
knows how much of an impact an MD/MPH dual degree can 
have on a career.
He spent the early part of his working life in emergency 
departments in Boston, New York, Florida, and the 
Washington, D.C., area. With his management acumen and 
his MPH, Budhrani says, he was empowered to climb the ER 
leadership ladder at an early age.
“I believe the two degrees, and my passion for medicine, 
helped me get to a place of clinical leadership at a rapid pace,” 
he says. The degrees also led him down an entrepreneurial 
track; Budhrani moved back to D.C. in the early 2000s 
and started one of the first multistate urgent care systems 
in the region. He then sold that venture and, with the help 
of another GW colleague, started a new company called 
CareClix Telemedicine, which offers global telehealth 
software solutions to help doctors see patients virtually.
“The foundation of the MD/MPH allowed me to do 
things in leadership roles in emergency medicine, start 
companies that I was able to exit successfully, and then go 
on and be an adviser for the Affordable Care Act (ACA) 
population health endeavors,” he says. His role in assisting 
with the insurance models in the ACA led him to pursue his 
current position at Innovation Health.
“All of these parts of my career built upon each other to 
help me achieve what I have today,” he says. “And much of it 
started at GW.”
Budhrani adds that public health and population science 
are very much in the spotlight today. “Our medical system 
has been created to deal with a one-on-one reactive type of 
care, which is extremely important; however, there needs to 
be additional focus on how we manage large populations of 
patients as well,” he says.
Bartholomew says faculty at SMHS are seeing not 
just a receptiveness on the part of students toward more 
public health in the curriculum offered, “but there is also an 
expectation that this will be part of their education in the 
MD program.”
Going for Two
The SMHS Physician Assistant Studies program also has a dual 
degree offering, which was launched in the late 1980s, becoming 
the first PA/MPH program in the nation at the time. 
The program averages about 14 students in each cohort, 
according to Howard Straker, EdD, MPH, PA-C, director of 
the PA/MPH program and assistant professor of physician 
assistant studies at SMHS. Students complete their public 
health course work in their first year at GW and spend their 
last two years in the PA program curriculum.
“The program is geared toward students who want 
to be clinicians who have the insights into the health of 
populations,” Straker explains. “Many have had previous 
experience working with underserved communities, public 
health settings, or research prior to applying. Some of the 
students intend to use their public health knowledge and 
skills to help them be better clinicians, while others intend 
to create careers where they are both clinicians and public 
health practitioners.” 
Bartholomew adds that having two degrees allows 
students to take their career one step further, no matter what 
they choose to do. 
“Given the changing health care landscape, given what we 
know of both worsening disparities and a growing awareness 
of influences on health that extend beyond the clinical setting, 
it makes ultimate sense to better prepare our clinicians 
to effectively address those issues by capitalizing on the 
strengths we have at GW,” Bartholomew says. 
Brown, who will complete the public health portion of 
her training at the end of the academic year, adds that she 
knows she has made the right decision in taking the time and 
investing the added tuition to pursue the dual degree. 
“It’s been a phenomenal last three years; it’s amazing how 
fast time goes by,” she says. “And to look back three years ago 
and realize how far I’ve come is incredible.” 
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H
ealth is commonly considered a fundamental 
human right. So is freedom from inequities 
due to differential access to quality care. That’s 
why health equity has been a key element of 
the George Washington University (GW) School of Medicine 
and Health Sciences’ (SMHS) strategic goals for many years. 
Now, a five-month series aims to further health equity educa-
tion among educators and health care providers while also 
fostering a shared understanding of the issues.
“We want to set people up for success and give them 
the tools to facilitate discussions on how we talk about race, 
power, and privilege in the classroom in a way that has both 
educators and students feeling safe and feeling included in 
the discussion,” says Maranda Ward, EdD, MPH, assistant 
professor of clinical research and leadership at SMHS, the 
creative mind behind the series.
The Department of Clinical Research and Leadership is 
sponsoring the five-month series, which began in September 
and will continue through January 2020.
The series, Ward says, will help attendees understand the 
importance of teaching about the social, environmental, and 
structural factors that threaten health equity; create inclusive 
policies and practices to address the challenges of health 
equity; and seek out equitable and sustainable institutional 
and community partnerships to advance health equity.
The idea for the series, Ward says, stemmed from a 
desire in the health sciences division of SMHS to create 
recommendations for faculty on addressing health equity in 
the classroom. 
“It’s not enough to create recommendations for the 
curriculum if the faculty and staff don’t feel comfortable and 
confident with these topics,” she says. “We want to make sure 
faculty are empowered to be proactive in these discussions.”
Ward says the series is open to the GW community 
and the public, and adds that the series is streamed through 
WebEx; sessions are archived online. 
Topics addressed include health disparities within and 
across important U.S. populations; root causes of health 
disparities in teaching and research; and how to talk about 
Homing in on
Health Equity
New Educational Series  
Sets Faculty Up for Success
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race, power, and privilege in the classroom.
“I created an external review committee of professionals 
and they weighed in on priority areas,” Ward says about how 
the topics were chosen. “We knew that when we’re talking 
about disparities, we need to talk about key populations to 
ensure people have the data around disproportionate health 
outcomes in U.S. populations. We also knew it would be 
important to show faculty and staff how to facilitate these 
discussions. You can have all the data you want, but you have 
to be comfortable talking about these issues.”
Speakers for the series include Ward; Abby Charles, 
MPH, senior program manager at the Institute for Public 
Health Innovation; Karey M. Sutton, PhD, director of the 
American Association of Medical Colleges Health Equity 
Research Workforce; and Howard Straker, EdD, MPH, PA-C, 
director of the PA/MPH program and assistant professor of 
physician assistant studies at SMHS.
Ward adds that the January session will be longer in order 
to have more hands-on activities and discussions, ensuring 
attendees are able to take what they learned and the resources 
offered and put them into practice. 
That session will also include “voice equity,” Ward says, 
through a panel discussion featuring community members 
who will talk about the work they are conducting related to 
health equity and projects happening on the ground where 
they live.
“Community partnerships are extremely important when 
it comes to health equity,” she says. “There are a lot of ways 
to talk about academic community partnerships. You can’t do 
this alone.”
Her goal for the series is for SMHS faculty to have a 
“renewed sense of urgency around understanding why this 
is important and having the agency and capacity to act, and 
enact change.” 
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A George Washington University (GW) research team led by Henry Kaminski, MD, chair of the Department of Neurology and Meta Amalia Neumann Professor of Neurology at the GW 
School of Medicine and Health Sciences (SMHS), recently 
received a $7.8 million award from the National Institutes of 
Health (NIH) to establish a rare disease network for myas-
thenia gravis. The network, which will join 24 existing NIH 
Rare Diseases Clinical Research Networks, will include 
basic and clinical investigators, patient advocacy groups, 
and biotechnology and pharmaceutical companies working 
together to enhance therapeutic development for this 
rare disease. 
Kaminski, a renowned expert in myasthenia gravis who 
has devoted decades of study to the disease, is joined on the 
team by fellow investigators Linda Kusner, PhD, associate 
research professor of pharmacology and physiology at SMHS, 
and Alison Hall, PhD, associate dean for research workforce 
development at SMHS. 
“Myasthenia gravis is a chronic autoimmune disease that 
affects how well the nerves and muscles communicate with 
each other. Often patients experience extreme weakness, 
struggle with their vision, and are even hospitalized because 
of difficulty breathing,” says Kaminski. “This grant will give 
the researcher community the needed infrastructure to study 
this rare disease in order to develop new therapies.”
BY LISA ANDERSON
The grant will fund research into the underlying 
pathophysiology of the disease. The different subtypes of 
myasthenia gravis are not well understood, there are no 
known biomarkers, and few research labs are studying the 
disease. Upward of 30% of patients are treatment resistant, 
and all suffer from undesirable or dangerous adverse treatment 
side effects. The research team will focus on the differences 
between ocular myasthenia and general myasthenia — subtypes 
that produce different antibodies that begin attacking nerve 
and muscle communication — and individualized treatments 
for the 10% of myasthenia gravis patients who develop tumors 
triggered by the disease. Additionally, the researchers will 
identify and collect biospecimens for future study and follow 
myasthenia gravis patients in order to identify biomarkers. 
To increase the research into myasthenia gravis, the grant 
also will support a career enhancement component featuring 
training and education opportunities for scientists, physicians, 
and the lay public. These opportunities will not only increase 
the pool of young investigators focusing their careers on rare 
diseases, specifically myasthenia gravis, but also improve 
awareness of the unique needs of myasthenia gravis patients. 
“The grant is not just a single project, but the 
establishment of a resource that will drive research for many 
years,” says Kaminski. “Other rare disease networks funded in 
the last 10 years have advanced treatments for these disorders 
that otherwise would have been impossible.” 
GW Researchers Receive 
$7.8 Million to Establish 
Rare Disease Network  
for Myasthenia Gravis
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A
fter serving as vice chair for the Microbiology 
Department at Rochester University for many 
years, Sanjay Maggirwar, PhD, MBA, knew it was 
time to consider moving into a full chair job, to at 
least test the waters of what was possible, but he didn’t want 
to go just anywhere. 
The George Washington University (GW) School 
of Medicine and Health Sciences (SMHS) was the only 
institution to which he applied.
Sitting in his office in Ross Hall mere weeks into 
his tenure as chair of the Department of Microbiology, 
Immunology, and Tropical Medicine (MITM) at SMHS, 
Maggirwar seemed confident and comfortable in his decision. 
He was drawn to GW, he says, for many reasons, but two in 
particular stood out: The DC Center for AIDS Research (DC 
CFAR) and the school’s work in HIV/AIDS.
“The CFAR here is much older and much bigger in scope 
and size than at Rochester, and I was involved with the CFAR 
there for almost 10 years. I strongly believe in the philosophy 
behind the center,” Maggirwar says. “Also, as an HIV 
researcher, I wanted to come to a city that would offer a lot of 
research opportunities in that field.”
His main research focus is on the inflammatory 
secondary complications of HIV infection experienced by 
those living longer with the disease. One of his major research 
projects looks at the inflammatory mechanisms associated 
with HIV-1 dementia. He also leads research projects 
looking at platelet-mediated neuroinflammatory responses 
to HIV and accelerated vascular aging in those undergoing 
combination antiretroviral therapy. 
However, Maggirwar’s career trajectory could have 
looked much different had he followed his first passion, 
acting. It’s clear that the theater was a place where his easy 
laugh and penchant for storytelling could shine.
“My path … it’s very unique. I never planned or had a 
dream to become a professor. Never. I was not a scholar in 
college, I was not studious, I was lucky to go to the next year,” 
he says with a broad smile and quick laugh. “My interest was 
in theater, and so I was very active on stage and involved with 
the professional theater for quite a long time in India.”
BY KATHERINE DVORAK
Eventually, however, Maggirwar’s father sat him down 
and asked him what he really wanted to do with his life. “I 
needed that talk,” he recalls, “and I started studying very 
seriously and my path started to become clearer.”
He earned his master’s degree and then an MBA, which 
led him to a job at a pharmaceutical company in production 
planning and control. Soon Maggirwar was spending most of 
his time in the quality control labs and conducting part-time 
research there in the evenings. One thing led to another, 
and he found himself with a PhD and on a path to medical 
research. “Since then I’ve never looked back, and I really enjoy 
what I do now,” he says.
Now at GW, Maggirwar is excited to make his mark 
on the MITM Department, starting with contributing to 
graduate education. He’s seeking to bring National Institutes 
of Health T-32 grants to GW, which support research training 
for groups of pre- and postdoctoral fellows.
“It’s a wonderful tool to recruit good graduate students 
into our program. So one focus is to enhance our footprint, 
both the number of students and quality of students who 
come here,” he says. “It would be the first T-32 at SMHS, and 
I would love to make that happen.” 
He adds that he would like to shape the research in 
the department and take it in novel directions, including 
enhancing collaborations within the department and with the 
basic science departments. 
“I’d also like to enhance our immunology footprint, 
as well as the virology component. We have really good 
researchers here, HIV researchers, but if we can get somebody 
with a background in flu research, that would be great, or in 
human immunology — those are the ideas I would like to 
think of for recruiting new faculty members,” he says.
Maggirwar says that even while pursuing his research 
career, he continued to dabble in the theater, including 
putting on shows in Rochester. However, with the 
opportunities and excitement of his new position ahead of 
him, he won’t be on stage anytime soon. 
That doesn’t mean he won’t be in the audience, though, 
taking in everything this city has to offer. 
A Second Act
Sanjay Maggirwar, PhD, MBA, Chair of Microbiology, Immunology, and Tropical 
Medicine, Hopes to Lead Department in Novel Directions
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of Medical 
Diplomacy
YEARS25
Celebrating 
January 2019 marked the start of the 25th anniversary year for the George Washington University (GW) School of Medicine and Health Sciences’ (SMHS) Office 
of International Medicine Programs (IMP). Since 1994, 
IMP’s academic and clinical exchanges have left an indelible 
mark on the more than 12,000 GW and international faculty, 
staff, residents, fellows, and students. 
“IMP has transformed lives and improved health care 
delivery around the world through medical education, training, 
research, and service,” says Huda Ayas, EdD ’06, MBA ’98, 
MHSA ’93, associate dean for international medicine and 
founding executive director of IMP. “We’ve gone from working 
with one country to more than 50 around the world. If you look 
around, this is really a unique program.”
BY THOMAS KOHOUT
IMP’s roots lie in a partnership that formed between GW 
and King Faisal Specialist Hospital and Research Center in 
Riyadh, Saudi Arabia, in 1993. At the time, Ayas assisted with a 
needs assessment that identified a list of issues at the hospital, 
including shortage of physicians, and developed physician 
training programs to help bridge the shortfall. IMP also invited 
Saudi students to enroll in GW’s dual-degree BA/MD program, 
recalls Ayas. 
From that initial project, IMP has grown to feature 
highly successful international MD, residency, and fellowship 
programs. IMP also offers a medical research fellowship 
program, an international observership program, continuing 
medical education for international faculty, and international 
clinical rotations for GW medical students.
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“We’re looking at all of our accomplishments and 
successes over the past 25 years, and we are looking for ways 
to strengthen those areas,” Ayas says, adding that she is 
preparing for the next steps for the program. 
“Research, patient care, education, and humanitarian 
aid; those are what IMP does well,” says Ayas, “and we’re only 
going to build on that in the future.” 
Medical diplomacy and bridge building have been 
hallmarks of IMP since the program’s earliest days. Through 
an exchange of faculty, students, and knowledge, IMP has 
sought to broaden perspectives and change people’s opinions 
about the world around them. 
Not long ago, Jeffrey S. Akman, MD ’81, RESD ’85, vice 
president for health affairs, Walter A. Bloedorn Professor of 
Administrative Medicine, and dean of SMHS, approached 
Ayas about leveraging the extensive network of academic and 
clinical contacts the program has developed over the years 
to enhance the school’s international collaborative research 
ambitions. 
With that mandate, IMP launched the Global Research 
Initiative in an effort to elevate GW’s international research 
profile and portfolio by partnering with internal and external 
stakeholders, facilitating scientific summits, and developing 
education and training platforms for students and scholars. 
The efforts led to scientific meetings in Brazil, Thailand, 
and Spain. Ayas adds that IMP submitted a proposal to 
conduct a fourth scientific meeting at King Saud University in 
Saudi Arabia later in the 2019–20 academic year. 
“This is really where we see the future growth for the 
Global Research Initiative, making contributions to GW and 
society by promoting international scientific collaborations 
and exposing researchers to their international counterparts, 
creating research training platforms for students,” says Ayas. 
In support of those expanded research ambitions, 
Fernando Vidal-Vanaclocha, MD, PhD, recently joined 
SMHS as an adjunct professor of biochemistry and molecular 
medicine and a research director with IMP. He will assist 
with the development and coordination of international 
scientific meetings, in addition to enhancing GW research 
collaborations with international medical and research 
institutions for the Global Research Initiative. 
Tackling the Human Side
Humanitarian efforts are another area Ayas hopes to grow 
in the program. For the past 15 years, IMP has partnered 
with Project Medishare, a nonprofit health organization, to 
organize biannual interdisciplinary trips to Haiti. Faculty and 
students from SMHS, the GW School of Nursing, and the 
Milken Institute School of Public Health at GW travel to the 
town of Thomonde to provide care in one of the world’s most 
resource-poor settings. 
The trips, led by Jack Summer, MD, RESD ’81, a former 
associate clinical professor of medicine at SMHS, along 
with infectious disease specialist Marc Siegel, MD, associate 
professor of medicine at SMHS, offer much needed care for 
residents as well as invaluable experience diagnosing and 
treating diseases of poverty. 
Now, IMP staff are exploring additional sites to develop a 
sustained effort of humanitarian support. “We are looking for 
more communities where we can have an impact, possibly one 
in Uganda and hopefully one in Mexico,” says Ayas. “Similar 
to our work in Haiti, we want to start sending students and 
faculty to [new places] to have a sustained impact on that 
community working with the local health care agents.”
To help advance those goals, Ayas is tapping into GW’s 
extensive alumni base. The site in Uganda, for instance, was 
part of an NGO, Omni Med, started by Ed O’Neil, MD ’87. 
The most important factor, she explains, is finding the 
right partners who can help identify needs and build capacity 
over the long term to make a sustained difference.  
Breaking Down the Barriers
Developing scholarships for SMHS students looking for 
international experiences is another area of emphasis for IMP. 
Often students choose not to participate in an international 
rotation for financial reasons. 
“We are working to eliminate that barrier,” says 
Ayas. “We don’t want any SMHS student to rule out an 
international learning experience because of financial 
considerations. Money should never be a reason a student 
decides he or she can’t study abroad.” 
To that end, in academic year 2018-19 IMP distributed 
nearly $67,000 in scholarships to support 26 SMHS students 
through the Leonard C. Akman Scholarship, the Max Kade 
Scholarship, the Haiti Medical Mission Scholarship, and 
the IMP Scholarships, formerly the International Clinical 
Electives Program scholarship.
“We’re changing lives by providing opportunities to 
students and professionals that they otherwise would never 
have,” Ayas says.
She adds that she is most proud of the fact that students 
who have participated in IMP offerings have gained a broader 
view of the world and have continued to seek out international 
exchange and humanitarian opportunities, and that the 
international students who have graduated from the program 
have gone on to make a positive impact at home. 
“We want to continue to accomplish that,” she says, “to 
develop high-impact programming to help people improve 
their health care systems and change people’s lives for 
the better.” 
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BY ASHLEY RIZZARDO
The 
Crossroads 
of Medicine 
and Public 
Health 
P
ostpartum hemorrhage — in which a woman 
experiences heavy bleeding after giving birth — is 
a rare but serious condition that, if not treated 
quickly, can result in shock and death. According 
to the American College of Obstetricians and Gynecologists 
(ACOG), postpartum hemorrhage accounts for about 10% of 
maternal mortalities. With the aid of a National Institutes of 
Health (NIH) career development grant, Homa Ahmadzia, 
MD, assistant professor of obstetrics and gynecology at 
the George Washington University School of Medicine 
and Health Sciences (SMHS), hopes to further minimize 
the chance of bleeding to ensure even more successful, 
healthy births.
The measure of postpartum hemorrhage, as well as how 
one defines it, has changed over time, according to Ahmadzia. 
“In the last two or three years the measurement changed from 
500 milliliters from standard delivery and one liter from a 
C-section. Now it is one liter across the board.”
Ahmadzia’s project is twofold. The first component is a 
statistical approach, attempting to optimize the prediction 
of who exactly is at risk for hemorrhage. “Clinically as 
OB-GYNs, we think of certain things, but they don’t 
always correlate with the outcome,” she says. “I’ve accessed 
and acquired different large data sets to pull all of the 
data together. First, I used traditional statistical modeling 
techniques to optimize prediction, and next I plan to use 
some machine-learning methods to look at these big data sets 
to hopefully optimize that prediction.” 
The second component involves optimizing the dosage 
of a preventive drug called tranexamic acid (TXA). Since 
the 1950s, the drug has been used to help reduce bleeding in 
dental procedures for patients with bleeding disorders, such as 
hemophilia. TXA also has been used in other surgical fields, 
such as transplant and cardiac surgery.
“In obstetrics there’s always a concern that if you give a 
drug to reduce bleeding that stabilizes the body’s ability to 
not bleed out, a pregnant woman could be susceptible to blood 
clots,” Ahmadzia explains. “The dose finding study that I am 
doing is trying to optimize the safest, lowest dose to prevent 
severe bleeding.”
In a large randomized international study called the 
WOMAN Trial, TXA reduced the chance of mortality from 
bleeding by 30%, especially if given early in the hemorrhage. 
The next logical question addresses prevention.
Over the course of Ahmadzia’s study, she and her team 
will administer three different doses to scheduled C-section 
mothers in low, medium, and high doses, with the maximum 
dose being no higher than what was administered in the 
WOMAN Trial.
“As for current preventative measures, the standard of 
care is oxytocin, given typically through IVs and sometimes 
through injection through the muscle,” she explains. “This is 
common practice in the United States. However, that’s the 
only intervention tool; there’s no other standard preventative 
medical therapy.”
Ahmadzia says that now is a great time to conduct a 
project such as this one because of recent pushes from ACOG 
and the state of California identifying hemorrhage and blood 
pressure as key issues to tackle. She references a group in 
California providing resources toward investigating how 
physicians can reduce hemorrhage through identification and 
prevention, and also treatment.
“We don’t 100% know if this will reduce transfusions at 
delivery, but it can reduce bleeding,” says Ahmadzia. “It could 
also reduce length of stay and improve the mother’s ability 
to care for her neonate. And it could reduce how many other 
medicines we give them. There are a lot of direct benefits 
for patients.”
The study is made possible by a K23 grant from NIH. 
The K23 is a mentored career development award geared 
toward ensuring that a researcher has the right mentor team 
supporting him or her and early footing to continue as a 
clinician-scientist. “The NIH puts as much emphasis on the 
project idea and the content proposal as they do on the person 
applying and what they hope to do with that award to further 
their career,” Ahmadzia says. 
In addition to the external support and that of her 
mentors, particularly Naomi Luban, MD, and Johannes van 
den Anker, MD, both in the Department of Pediatrics at 
SMHS, she says she is appreciative of the internal support, 
noting the encouragement from Nancy Gaba, MD, Oscar 
I. and Mildred S. Dodek and Joan B. and Oscar I. Dodek 
Jr. Professor of Obstetrics and Gynecology, and chair of the 
Department of Obstetrics and Gynecology at SMHS. “Dr. 
Gaba is instrumental in supporting clinician-scientists and 
research interests. … if your institution and your department 
don’t support you, this can be very difficult.”
Looking forward, Ahmadzia was inspired by a recent 
encounter with Ian Roberts, MD, who is the senior investigator 
from the WOMAN Trial, to develop a multisite clinical 
study. Using the high patient volume and diverse patient 
demographics from hospitals throughout the D.C. metro area, 
she will pursue the important next step of determining whether 
the intervention works on a wider scale. 
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FACULTY NEWS
Faculty Focus
Members of the George Washington 
University (GW) School of Medicine 
and Health Sciences (SMHS) faculty 
gathered Sept. 19, 2019, to be honored 
for their years of service, commitment 
to the institution, and great 
achievements made while working at 
SMHS.
Jeffrey S. Akman, MD ’81, 
RESD ’85, vice president for health 
affairs, Walter A. Bloedorn Professor 
of Administrative Medicine, and dean 
of SMHS, recognized Ray Lucas, MD, 
senior associate dean for faculty affairs 
and health affairs, who is stepping 
down from his position. Akman thanked 
Lucas and recognized his “outstanding 
leadership and service” in the role. 
Recognition was given to SMHS 
Emeriti faculty, promoted and tenured 
faculty, faculty celebrating more than 
five years of service, as well as faculty 
members who were honored with 
distinguished awards focused on great 
research, service, and education.
Robert H. Miller, vice president 
for research at GW and senior 
associate dean for research at SMHS, 
presented the first three awards, which 
included the Early Career Research 
Achievement Award, presented to 
Colin Young, PhD, assistant professor 
of pharmacology and physiology (1); 
the Elaine H. Snyder Cancer Research 
Award, earned by Lopa Mishra, MD, 
director of the Center for Translational 
Medicine and professor of surgery 
(2); and the Distinguished Researcher 
Award, presented to Raja Mazumder, 
PhD, professor of biochemistry and 
molecular medicine (3).
Yolanda Haywood, MD, RESD ’87, 
BA ’81, senior associate dean for 
diversity and inclusion and associate 
dean for student affairs, presented the 
Diversity and Inclusion Award to Denice 
Cora-Bramble, MD, MBA, BS ’76, 
professor of pediatrics (4).
Akman presented the 
Distinguished Service Award to Katalin 
Roth, MD, professor of medicine (5). 
The final three awards, the 
Distinguished Teacher Awards, which 
this year were expanded to include all 
faculty in SMHS, were presented by 
Ellen Goldman, EdD, MBA, associate 
dean for faculty and organizational 
1 2
3 4
5 6
7 8
development. Awards went to Nick 
Shworak, MD, PhD, associate professor 
of pharmacology and physiology, 
for Basic Sciences (6); Holly Jonely, 
ScD, MPT, associate director of the 
Physical Therapy Program and assistant 
professor of health, human function, 
and rehabilitation sciences, for Health 
Sciences (7); and Dewesh Agrawal, 
MD, professor of pediatrics, for 
Clinical Sciences (8). 
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Bringing surgical expertise abroad is 
the goal of the Global Brainsurgery 
Initiative, an organization co-created 
by Walter Jean, MD, professor of 
neurological surgery at the George 
Washington University (GW) School 
of Medicine and Health Sciences; 
Hasan Syed, MD, a neurosurgeon 
with the University of Virginia Health 
enthusiastic reactions to this from both 
patients and trainees,” Jean said. “They 
really value the care and training we 
are able to provide.”
The team performed 13 complex 
brain operations while in the country, 
and even had the opportunity to sit 
down with Panama’s first lady, Yazmín 
Colón de Cortizo, a double GW alumna 
who earned her master’s degree in 
1984 and her bachelor’s degree in 
1981. Jean said the group spoke with 
her about the state of health care 
in Panama.
The Global Brainsurgery Initiative 
also is starting to grow, Jean added. A 
previous trip to Vietnam was a success, 
and he is hopeful teams will be able to 
train and conduct operations in other 
countries in the future. The organization 
has support from the Foundation for 
International Education in Neurological 
Surgery, as well as financial backing 
from virtual reality technology company 
Surgical Theater. 
System; and Daniel Roque Felbaum, 
MD, an endovascular neurosurgeon at 
Georgetown University. 
In the summer of 2019, Jean 
and six other neurosurgeons trav-
eled to Panama to perform complex 
neurosurgical procedures and to help 
educate physicians in the country on 
neurosurgical techniques. “We’ve had 
Global Brainsurgery Initiative
Kenneth Harwood, PhD, PT, director 
of the Health Care Quality Program, 
research director for the Physical 
Therapy Program, and associate 
professor of clinical research and 
leadership at the George Washington 
University School of Medicine and 
Health Sciences, was a co-author on a 
paper that received the 2019 John M. 
Eisenberg Article-of-the-Year award 
from Health Services Research.
The paper, titled “Physical therapy 
as the first point of care to treat low 
back pain: An instrumental variables 
approach to estimate impact on opioid 
prescription, health care utilization and 
costs,” compared differences in opioid 
prescriptions, health care utilization, 
and costs among patients with low 
back pain who saw a physical therapist 
at the first point of care. The research 
team found there was lower utilization 
of high-cost medical services, as well 
as lower opioid use, when patients saw 
a physical therapist first. 
The annual award was established 
in 2003 and recognizes excellent 
and original research among articles 
published in the Health Services 
Research journal. Awardees are 
selected by the co-editors-in-chief, 
the senior associate editors, and the 
publisher based on the overall quality 
of the article and its relevance to policy 
Harwood Co-Authors Paper Selected as  
John M. Eisenberg Article-of-the-Year
areas that Eisenberg worked in or 
promoted during his tenure as director 
of the Agency for Healthcare Research 
and Quality. 
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Kaylan Baban, MD,  
MPH, Named New  
Chief Wellness Officer 
Burnout is more prevalent among 
health care and health sciences 
workers, professionals, and trainees 
than among the general U.S. popula-
tion, and to help tackle the growing 
issue Kaylan A. Baban, MD, MPH, has 
assumed the role of chief wellness 
officer for the George Washington 
University (GW) clinical enterprise.
As chief wellness officer, Baban will 
lead the GWell Center for Healthcare 
Professionals, which aims to promote a 
broad concept of health and wellness 
for all members of the GW medical 
enterprise. Created on the basis of 
feedback from a wellness task force, 
the center’s mission is to promote a 
culture of wellness as the foundation 
of professional excellence, support 
skills development for personal and 
professional wellness, and provide 
leadership to identify and minimize 
structural stressors. 
Aileen Chang, MD, MSPH, Among 
Finalists for CureAccelerator Live!
George Washington University (GW) researcher 
Aileen Chang, MD, MSPH, was chosen as a finalist for 
CureAccelerator Live! for the Developing World, a philan-
thropic pitch competition to find the next breakthrough 
clinical repurposing treatment.
Chang, an assistant professor of medicine and of 
microbiology, immunology, and tropical medicine at the GW 
School of Medicine and Health Sciences, delivered her pitch, 
“Repurposing a Flu Treatment for Severe Dengue Patients in 
Colombia,” at the May event. CureAccelerator Live! is hosted 
by Cures Within Reach, a philanthropic leader in drug, 
device, and nutraceutical repurposing research.
Chang is recommending further investigation of the 
medication Zanamivir, which has been approved by the U.S. 
Food and Drug Administration to treat Influenza A and B. 
The treatment has been shown to decrease vascular leakage 
caused by dengue, which is the primary cause of death in 
severe infections. 
“There is a need nationally for 
initiatives that support those working 
in health care in all capacities, whether 
administration, building services, or 
direct patient care,” said Baban, who is 
also the director of the Lifestyle Medicine 
Program at the GW Medical Faculty 
Associates and assistant professor of 
medicine at the GW School of Medicine 
and Health Sciences. “There is recogni-
tion from leadership that this is a national 
challenge, and a proactive culture of 
wellness is necessary to be the best insti-
tution that we can be, the best place for 
us to work, and the best place to receive 
your health care.” 
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Steven Davis, MD, RESD ’08, assistant 
professor of emergency medicine at 
the George Washington University 
(GW) School of Medicine and Health 
Sciences (SMHS), has been selected as 
the 2019 National Clerkship Director 
of the Year at the Society for Academic 
Emergency Medicine.
Davis serves as the student 
clerkship director of the Emergency 
Medicine Senior Clerkship at SMHS, is 
on the Committee for Undergraduate 
Medical Education Curriculum, and 
is chair of the Clinical Curriculum 
Subcommittee at GW. 
Researchers at the 
George Washington 
University (GW) are 
laying the ground-
work for a future in 
which health care 
providers can more 
accurately diag-
nose brain injury 
and dysfunction in 
newborns with the 
use of an inexpensive 
and non-invasive 
diagnostic tool — 
electroencephalography (EEG). 
The research, led by Matthew 
Colonnese, PhD, associate professor 
of pharmacology and physiology at 
the GW School of Medicine and Health 
Sciences, was recently funded with 
more than $4 million in grants from the 
National Eye Institute and the National 
Institute of Neurological Disorders 
and Stroke.
The researchers seek to expand 
current knowledge of how changes 
in brain connections to the cerebral 
GW Researcher 
Investigates Role of 
BRCA1 in DNA Repair
A research team led by Yanfen Hu, PhD, 
professor of anatomy and cell biology 
at the George Washington University 
(GW) School of Medicine and Health 
Sciences and a member of the GW 
Cancer Center, is studying the role of 
the tumor suppressor BRCA1 in the 
homologous recombination pathway of 
DNA double-strand break repair. 
“Our work seeks to validate a 
previously unrecognized role of BRCA1 
in licensing the commitment step in 
homologous recombination [a type 
of high-quality repair machinery that 
faithfully repairs DNA double-strand 
breaks],” said Hu. “This challenges the 
current view of BRCA1 as merely a scaf-
folding protein.”
Based on preliminary data, 
the team hypothesizes that BRCA1 
modifications are part of a licensing 
mechanism that senses the damage, 
but manages to time the repair to 
that window of high-quality repair. 
Interestingly, both nuclease recruit-
ment and inhibition are part of the 
timing control strategy. They also 
propose that BRCA1 homologous 
recombination repair activity is particu-
larly important for genetic integrity of 
luminal genes in luminal cells of breast 
tissue, where many BRCA1-associated 
tumors originate. 
cortex control the normal development 
of brain activity that occurs around the 
time of birth.
Despite more than 65 years of 
EEG use on newborns, understanding 
of rhythmic cortical activity patterns 
associated with brain development and 
injury is limited. The funding will enable 
the research team to help improve the 
interpretation and understanding of 
the EEG in babies, both preterm and 
full term. 
Matthew Colonnese, PhD, Seeks to Improve 
Diagnostic Utility of Neonatal EEGs
The award recognizes an emer-
gency medicine clerkship director who 
has made significant contributions 
to either a third- or fourth-year emer-
gency medicine rotation. 
“It’s an honor to be recognized 
for our Emergency Medicine Senior 
Clerkship,” said Davis. “Awards like 
this are a recognition of the whole 
educational team. It takes a whole 
department to build a successful 
educational program.” 
Steven Davis, MD, Recognized  
as National Clerkship Director of the Year
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ail Lebovic, MD ’86, can confidently look back on her 
decades as a surgeon and an entrepreneur and see the 
effect her work has had in the field of women’s health 
care, and particularly on innovative surgery for women 
with breast cancer.
As one of the few people, and few women, involved in 
breast-conserving surgery in the 1980s, Lebovic traveled 
around the world attending meetings with surgeons who 
shared her passion for the issue. 
“At the time … only a handful of surgeons in various parts 
of the world [were] interested in improving surgical outcomes 
for breast cancer. There were some surgeons in France, 
Italy, and New Zealand, and we would get together 
at international meetings and talk about this,” 
she says. “We discussed ways we could save 
the skin of the breast and make different 
and hidden incisions, as well as performing 
immediate reconstruction.” 
The real goal, she says, was saving the 
breast without having a negative impact on 
survival from the cancer. “A new term was coined 
for this approach to breast surgery: oncoplastic 
surgery,” Lebovic says, “which combines techniques 
in surgical oncology with aesthetic and reconstructive 
techniques.
“I was the only woman surgeon in the United States really 
pushing for this, that’s for sure,” she adds.
Nearly three decades since those early days, Lebovic has 
developed eight medical device startups, all of which have 
been acquired and have products still on the market today. 
Innovator
The
Gail Lebovic, MD ’86, Turns 
Passion for Problem Solving into 
Creation of Medical Devices
BY KATHERINE DVORAK
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Lebovic’s inventions are “relatively simple ideas that came 
out of a clinical need,” she says. They include the MammoPad, 
which cushions the breast during a mammogram; the Expand-
a-Band Breast Binder, which helps women recovering from a 
mastectomy; the SAVI, which helps deliver targeted radiation 
to the breast; and most recently the BioZorb, an implantable 
device that marks the surgical site where a tumor is removed.
It wasn’t the path Lebovic imagined for herself when she 
attended the George Washington University (GW) School 
of Medicine and Health Sciences (SMHS), but it’s a path she 
says the school more than adequately prepared her to travel. “I 
truly believe one of the critical aspects of success has been the 
incredibly strong clinical foundation I obtained while at GW,” 
she says. “In everything I’ve done, that really strong clinical 
foundation is what helped me excel in so many different 
aspects of medicine.”
When asked if she’s always been an innovator, Lebovic 
replies with a thoughtful “yes.”
As a surgeon, “I loved being able to diagnose a clinical 
problem and fix it,” she explains. “I think that’s where 
that innovative spirit, that entrepreneurial spirit, comes 
from: being able to recognize a problem and carefully and 
thoughtfully come up with a creative solution, while avoiding 
risks whenever possible.”
While she was at GW, a close family friend died from 
breast cancer, pushing Lebovic to learn more about the 
disease. Not long after, Bernie Fisher, MD, a pioneer in the 
treatment of breast cancer who conducted one of the pivotal 
studies in breast-conserving surgery, spoke to students on 
campus at SMHS. 
“I remember sitting in the lecture hall going ‘Wow, this is 
kind of crazy stuff,’ ” she says. “Almost all women with breast 
cancer were having mastectomies, and I had seen my first 
mastectomy and was pretty shocked, and was thinking, ‘does 
every woman who has breast cancer have to go through this?’ ” 
After that, Lebovic says, she was set on her career path, 
seeking to find or develop better, more creative ways to 
improve the surgical approach through the art of oncoplastic 
surgery, a subspecialty using reconstructive surgical 
techniques to shape the remaining breast after removal of 
a tumor.
Eventually, Lebovic’s innovative spirit drew her toward 
the field of medical devices. In the 1990s, she spent a lot of 
time consulting for device makers, which led her to want to 
start her own companies that could develop medical products 
designed to help women. 
With the help of engineer George Hermann, whom 
Lebovic had worked with in the past, ideas started to turn 
into actual products. “We would do the research, and once 
we were confident we had a winning product design, we 
would raise money and build the companies ourselves,” she 
says. “I bring the clinical design and strategic aspects and 
he brings the engineering, regulatory, and quality aspects 
to the table. Then together we assemble a team to help with 
the work. It really is all about the people, their talent, and 
our ability to work together. It’s an incredibly rewarding and 
fun experience.”
The culmination of many aspects of Lebovic’s clinical 
work, she says, can be found in the BioZorb, a simple yet 
elegant-looking device that’s actually very complex in what 
it can do. The device is implanted during surgery after 
the tumor is taken out; it’s placed where the tumor was 
removed, and the surgeon sutures it into the breast tissue, 
allowing the tissue to grow into the center of the device. 
The BioZorb consists of a bioabsorbable framework, which 
can be reabsorbed by the body over time, leaving behind six 
permanent titanium clips to mark the surgical site.
The device helps to maintain the contour of the breast 
and allows the tissue to heal with support and to re-form 
instead of collapsing. The clips enable the spot to be easily 
found during mammography for follow-up, and it helps the 
radiation oncologists target the area that needs treatment. 
The product has been used to help nearly 100,000 women, 
Lebovic says. Focal Therapeutics, the company that Lebovic 
and Hermann founded to produce and market BioZorb, 
was acquired last October by women’s medical technology 
company Hologic for $125 million. 
It’s gratifying to be a surgeon and have one-on-one 
relationships with patients, Lebovic says, but you can help 
only so many people directly. However, “when you become 
an entrepreneur and invent something that improves patient 
care, now you can impact millions of women all at once.” 
The same goes for teaching, she notes. About 13 years 
ago, Lebovic founded the School of Oncoplastic Surgery. 
Two courses are held each year, and plans are in the works 
to expand and include online courses as well. “We’ve trained 
a thousand surgeons through our school from all around 
the world, and each one of those surgeons impacts several 
hundred women a year, so now I’m able to ‘touch’ 2 million 
women or more a year, something I could never do if I only 
stayed in practice,” she says. 
With all she’s done, all the 100-hour workweeks over the 
years, people sometimes ask Lebovic if she’s going to retire, 
but she says there’s always something in the pipeline. 
“It would be impossible for me to retire. It’s not in my 
blood, and besides, why retire when you love what you do and 
can change history in medicine? In my career I’ve just put 
one foot in front of the other … and opportunities just kept 
presenting themselves to me,” she says. “I never planned all of 
this, but looking back on it all, it looks so well-orchestrated.” 
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articipation in a research scholarly concentration is an 
important step in giving medical students the aspira-
tion to become physician-researchers, regardless of 
their research experience before entering medical 
school, according to a new study published in the Journal of 
Investigative Medicine. 
The study found that students in the George Washington 
University (GW) School of Medicine and Health Sciences 
(SMHS) Clinical and Translational Research (CTR) scholarly 
concentration were more likely to place in a highly selective 
residency (40.2% vs. 21.6%), 68% more likely to publish 
after medical school, and almost four times as likely to take 
a job at an academic health center compared with their 
non-concentration peers.
“We had predicted that students who came into medical 
school with a lot of research were more likely to be successful 
because they had experience,” says author Alison Hall, PhD, 
associate dean for research workforce development at SMHS. 
“But what surprised us was that it didn’t matter if you’d done 
two years at the NIH or you’d never touched a test tube — 
the CTR scholarly concentration had a significant impact on 
medical students who go on to research careers.”
About 20% of first-year medical students at SMHS 
choose research as their concentration, a focused elective 
program the school has been running for more than a decade. 
Hall and the study’s other authors, Laura Radville, PhD, 
former research program manager at SMHS; Annette Aldous, 
MPH, senior research assistant at the Milken Institute School 
of Public Health at GW; and Jennifer Arnold, former program 
assistant, compared data from 335 graduates from 2009 to 
BY KATHERINE DVORAK
2018 who participated in the research concentration with 
data from the same number of graduates with no scholarly 
concentration.
Hall says the timing of the research scholarly 
concentration may have a larger impact than research prior to 
medical school because students are learning about research at 
the same time they are immersing themselves in medicine. 
The SMHS research scholarly concentration, led by Hall 
and Naomi Luban, MD, chair of the Institutional Review 
Board and medical director of the Office for the Protection of 
Human Subjects at Children’s National Health System, offers 
“a brisk exposure to research,” Hall notes. The concentration 
matches students with mentors in their area of interest and 
consists of a research lecture series, a large research project 
conducted during the first and second years of medical school, 
research presentations, and a scholarly project, such as a 
research manuscript submitted for publication or a poster 
presentation at a professional meeting.
Hall adds that she and Luban are now using the data 
collected in the study to examine additional experiences that 
can be offered to SMHS students. They’re considering how to 
link the concentration to a year off for research, or match it to 
research in residency programs that follow medical training. 
“How do we enrich this for people who really want to keep 
going? How do we create a real career path for people who 
discover in medical school that this is for them?” Hall asks. 
She adds that she’s excited about the findings and the 
level of success of the concentration. “I think what will be 
interesting is what steps we take next to enrich the students’ 
environment,” she says. 
Scholarly Concentration Boosts Research Interest
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Family history of breast cancer 
drives student’s passion for 
oncology, health equality
a Calling
Following
BY KATHERINE DVORAK
I think [the medical field] is just the perfect thing for me.”
Thomas discovered the ASTRO fellowship during a 
search for summer experience opportunities. It was created 
to introduce medical students from underrepresented 
backgrounds to the field of radiation oncology and 
to provide them with exposure to clinical, basic, and 
translational research.
During the summer, Thomas conducted research with 
ASTRO member Curtiland Deville, MD, clinical director of 
radiation oncology at Johns Hopkins Kimmel Cancer Center 
at Sibley Memorial Hospital, on the use of photon and proton 
therapies in soft tissue sarcomas.
In addition to the research, Thomas had the opportunity 
to join Deville on his rounds in the clinic, observing how he 
interacts with patients. “I really liked the consults because 
they were very educational,” she explains. “Sometimes patients 
come in feeling very unsure, and I like that when they leave, 
they feel more confident about what they’re going to do.”
She also spent time in the clinic with other radiation 
oncologists, which allowed her to learn about additional 
cancers, including prostate, breast, lung, head and neck, and 
even pediatric cases.
“This experience has strengthened my desire for a career 
in radiation oncology,” she says. “There are so many different 
advancements coming in the field, and it combines all the 
things I like, including imaging and being able to care for 
patients, and there’s a genetics aspect to it.”
Thomas is grateful every day to be in medical school. 
“I’m following my dream, and not everyone is lucky enough to 
say that.” 
R
ehema Thomas knows firsthand the negative 
impacts of social determinants of health; her 
mother and two aunts had breast cancer and 
one of her aunts died from the disease. Now in 
medical school at the George Washington University (GW), 
she sees everything through that lens.
“They all had it pretty aggressively and pretty young. I’ve 
seen how social determinants of health affected my aunt, and 
I wonder if things had been different, would there have been 
a different outcome?” she says. “For me, especially being a 
woman of color, my family history of breast cancer has really 
made me focus on that and the fact that across almost all of 
the cancers, African Americans have a higher mortality rate.”
Thomas is only a second-year MD student at the GW 
School of Medicine and Health Sciences, but she already 
knows oncology is her calling, and has found herself drawn 
to radiation oncology in particular. In fact, she recently 
participated in the prestigious American Society for Radiation 
Oncology’s (ASTRO) Minority Summer Fellowship.
“Radiation oncology is a field that’s lacking in diversity, 
and that is something I want to make a change in,” she says. “I 
want to make a difference in these outcomes because everyone 
deserves an equal chance at survival and beating cancer.”
Thomas’ interest in medicine started when she was a child 
wandering the halls of the hospital where her father worked as 
a cardiologist. She recalls seeing him read echocardiograms, 
and remembers enjoying being with him at the hospital. 
“A lot of the time we’d be in the telemetry unit and I’d be 
asking the nurses questions about the EKG readings on the 
screen,” she says. “I naturally was drawn to math and science. 
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here are those who talk about what needs to be 
done, and those who just do it. It’s safe to say David 
Rapp, MD ’01, falls into the “just do it” column. 
When he entered his third year of medical 
school at the George Washington University (GW) School 
of Medicine and Health Sciences, Rapp got his first glimpse 
of the desperate need for medical care around the world 
by participating in a medical mission as part of his MD 
curriculum. “I went to Honduras for a week and it was a 
transformative experience.”
That first trip left an indelible impression on Rapp, 
who today serves as an associate professor of urology at 
the University of Virginia. Ultimately, it would prompt 
him to act on the need he witnessed during that medical 
mission, forming his own nonprofit medical philanthropic 
organization, Global Surgical Expedition (GSE). 
“Once you’ve taken one trip, you’re committed forever,” 
says Rapp. “I always knew that I wanted to [travel and 
work in underserved regions], but I also wanted to make a 
bigger impact. 
“My mother is a storyteller and she taught me the power 
of stories,” Rapp explains. “So, I wanted to use stories to help 
inspire other physicians and health care professionals to join 
the global effort to treat surgical illness.” From its beginning, 
Rapp has ensured that GSE lives this mission, offering a 
catalog of inspirational stories from patients, health care 
volunteers, and GSE trips through videos and blogs posted on 
the nonprofit’s website. 
As a high school student, Rapp developed a serious 
interest in language, particularly Spanish. He even majored 
in Spanish as an undergraduate at the University of Virginia. 
Medicine, however, was always his end goal. Because he came 
from a family of physicians — both his father and grandfather 
were doctors, and his brother also practices medicine — 
health care was a big part of his world view from an early age. 
Rapp’s grandfather was a primary care physician in 
TRANSFORMATIVE 
MEDICINE
A Medical Mission as a Third-Year 
Medical Student Provided 
David Rapp, MD ’01, with a Global 
Perspective on Health Care
BY THOMAS KOHOUT
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organizing missions, GSE has grown. It now sends out five 
surgical teams annually — to not only Central America, 
but also Africa. Together, GSE volunteers have performed 
more than 300 surgeries and treated more than 750 patients 
afflicted by cancer, fistula, kidney stones, urinary blockage, 
and other devastating illnesses.
Beyond the life-restoring surgeries performed during 
each trip, the sustained impact from training local physicians 
is the key contribution of GSE — and it’s a big part of what 
drives Rapp. “Sometimes education is as meaningful as doing 
a surgery,” he says. “If you can educate local surgeons and 
teach them how to perform a particular procedure, they can 
each do 100 of those surgeries in a year, while I can only do a 
few of them while I’m there.
“It’s those trips that truly reinforce the privilege that it 
is to be a physician,” Rapp continues. “You look back at the 
years of schooling and training, and it’s trips like these [that 
make] you realize it was worth it.” 
rural Illinois, and Rapp recalls visiting the clinic where he 
worked, “learning how a stethoscope worked, playing with the 
centrifuges. Those things were really exciting. I think it was 
always something I envisioned doing.”
Those diverse interests and zeal for language laid an 
ideal foundation for Rapp’s future international work. When 
it came time to apply for medical school, Rapp says, GW 
topped the list. “I was obviously attracted to the quality of the 
education and the school itself, but I was also interested in the 
community in and around GW. There is a real international 
flair. GW is known for being a hub of international relations 
and work within Washington, D.C.” 
Following graduation from GW, the completion of his 
residency at the University of Chicago, and a fellowship at 
Virginia Mason Medical Center, Rapp sought out more global 
health opportunities. The young urologic surgeon visited 
Belize — a tiny nation perched along the eastern edge of 
Central America, bordered by Mexico, Guatemala, and the 
Caribbean Sea — and discovered a region in desperate need of 
his skills. 
“I expected on my first trip to go and perform a number 
of very complicated surgeries,” recalls Rapp, who specializes 
in reconstructive urological surgery. “When I got there, what 
I found was a lack of urologic care, often very basic care that 
we take for granted in the United States, that was resulting in 
lifelong disability or even death [in Belize].”
Common problems such as kidney stones, which 
elsewhere are treated very simply, he explains, plagued the 
local population, leaving patients on dialysis or even costing 
them their lives. “It really motivated me to set up a hub and 
focus our efforts down there, because I knew that we could 
make such a big difference.”
Rapp and Tim Bradford, MD, a partner at the Virginia 
Urology Center who joined him on the trip, returned to the 
United States committed to do even more. In 2012, they 
founded GSE, providing surgical care and boosting regional 
health care capacity by offering equipment and training to 
local surgeons. Over the seven years the nonprofit has been 
David Rapp, MD ’01, and his father Michael Rapp, MD, 
JD ’75, an emergency medicine physician, had the 
chance to work together on a mission to Belize. It was 
“one of my true pleasures having my father  
join me on a GSE trip,” recalls the  
younger Rapp. 
“ Sometimes education is as 
meaningful as doing a surgery. 
If you can educate local 
surgeons and teach them how to 
perform a particular procedure, 
they can each do 100 of those 
surgeries in a year, while I 
can only do a few of them while 
I’m there.”
— David Rapp, MD ’01
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CLASS NOTES
1960s
Irwin Koff, MD ’69, a family physician, received a 10-year 
service award from the Kalihi Palama Health Center in 
Honolulu, Hawaii.
Jerome Mayersak, MD ’64, RESD ’69, received the 
Distinguished Alumni Urology Award from the Department 
of Urology at SMHS during the annual Harry C. Miller 
Symposium and Luncheon.
1970s
Richard Roger Ware, AS ’76, past department comman-
dant, Marine Corps League (MCL), was elected as the MCL 
Mideast Division National Vice Commandant. Ware, who 
held positions as sergeant-at-arms and chief of staff prior 
to being elected as department commandant in 2009–11 
and 2013–15, earned his associate’s degree in medical 
services technology.
Joseph René Smith, MD ’80, BS ’74, recently returned from a 
volunteer mission to Vietnam. Smith was one of two desig-
nated medical directors for the Vietnam Health Clinic (VHC), 
a student-run volunteer organization with the University 
of Washington. The group is responsible for setting up 
mobile medical clinics in rural Vietnamese villages to deliver 
medical and dental care to underserved populations.
This was Smith’s sixth visit to Vietnam as a medical volunteer, 
and his fifth with VHC. 
This year students and health professionals worked in 
villages west of Da Nang in Central Vietnam. They treated 
more than 1,700 villagers — including a large number of 
children — over a two-week period and eight full clinic days. 
Smith began his academic career at the George Washington 
University’s Columbian College of Arts and Sciences in 1970, 
two months after returning from a one-year tour of duty in 
Vietnam serving with the United States Marine Corps.
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1980s
Dominick Gadaleta, MD ’86, was 
recently named chair of surgery 
at Southside Hospital, a 300-bed 
facility that is part of Northwell Health 
Physician Partners in Bay Shore, 
New York.
Michael Goldrich, MD ’89, RESD ’91, 
an ENT-otolaryngologist based in New 
Brunswick, New Jersey, was featured 
by Castle Connelly Top Doctors as a 
“Top Doc” in the New York metro area. 
Richard Popiel, MD ’81, RESD ’85, 
BS ’75, has joined health care tech-
nology company BioIQ as a senior 
adviser. Popiel most recently served as 
co-founder and managing partner of 
Xploration Health, LLC.
James Roberts, MD ’84, a urologist in 
private practice, was named a top-
rated urologist in San Diego, California, 
by Kev’s Best, an independent blog 
and news site. Roberts opened his 
private practice in 2004 after retiring 
as chair of the Department of Urology 
at the Naval Medical Center San Diego 
after 20 years.
Edward M. Zimmerman, MD ’83, was 
recently appointed to the medical advi-
sory board of Apyx Medical Corporation, 
formerly Bovie Medical Corporation. 
Zimmerman also serves as president 
and examiner for the American Board 
of Laser Surgery, and is a member of 
the board of trustees for the American 
Academy of Cosmetic Surgery.
1990s
Jeffrey Bell, MD, RESD ’93, recently 
merged his practice, Commonwealth 
OB-GYN, with that of Thomas E. 
Myers, MD, to form Novant Health 
UVA Health System OB-GYN, based in 
Warrenton, Virginia. 
Bookshelves
In his new book, “A Modern 
Contagion” (Johns Hopkins 
University Press, 2019), 
Amir Afkhami, MD ’03, 
PhD, associate professor 
of psychiatry and behavioral sciences 
at the George Washington University 
School of Medicine and Health 
Sciences, uses Iranian, European, and 
American archival records to establish a 
comprehensive overview of pandemic 
cholera in Iran from the early 19th 
century to the First World War. Tracking 
those historical outbreaks, Afkhami 
argues that the effects of pandemic 
cholera played a significant role in 
altering the country’s social, economic, 
and political development, ultimately 
molding modern Iran. 
Walter Jean, MD, professor 
of neurological surgery, 
recently published “Skull 
Base Surgery: Strategies” 
(Thieme Medical 
Publishers, 2019), a 455-page text that 
has quickly became one of the top new 
neurosurgery books. Jean, a board-
certified neurosurgeon with 15 years 
of experience in both open and endo-
scopic skull base surgery, focuses on 
state-of-the-art skull-base procedures, 
important thought processes, and vital 
strategies required to perform them.
The text is broken into nine sections 
and 32 chapters, organized by anatomy 
cover tumors in the anterior, anterolat-
eral, lateral, central, postero-superior, 
and postero-inferior skull base regions, 
and clivus, petrous bone, and ventricles. 
Real-life cases enhance understanding of 
all the elements that go into each opera-
tion. Perspectives sections at the end of 
each chapter embrace the concept of 
diverse surgeon viewpoints on similar 
ideas, techniques, and approaches. 
Susan McCormick, MD 
’88, a gastroenterolo-
gist with Virginia Mason 
Health System in Seattle, 
Washington, recently 
published her debut novel 
“The Fog Ladies” (The Wild Rose Press, 
2019). The mystery novel, McCormick’s 
first, is set in San Francisco’s storied 
Pacific Heights neighborhood. 
McCormick also published a children’s 
book titled “Granny Can’t Remember 
Me” about Alzheimer’s disease and 
dementia told from the perspective of 
a 6-year-old. 
Christina M. Puchalski, 
MD ’94, RESD ’97, 
founder and director of 
the George Washington 
University’s (GW) 
Institute for Spirituality 
and Health and professor of medi-
cine at GW School of Medicine and 
Health Sciences, partnered with Betty 
Ferrell, PhD, MA, FAAN, FPCN, CHPN, 
director and professor in the Division 
of Nursing Research and Education, 
Department of Population Sciences, 
at City of Hope Hospital, on a new 
book about spirituality and palliative 
care. The book, titled “Making Health 
Care Whole” (Templeton Press, 2019), 
serves as both a scholarly review of 
the field as well as a practical resource 
with specific recommendations to 
improve spiritual care in clinical 
practice. Puchalski and Ferrell provide 
definitions and chart a common 
language for addressing spiritual care 
across the disciplines of medicine, 
nursing, social work, chaplaincy, and 
psychology, and they present models 
of spiritual care and offer tools for 
screening, assessment, care planning, 
and interventions.
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CLASS NOTES
IN MEMORIAM
Paul Joseph Anderson, MD ’88
Doris Martens Araujo, MD ’51
Gregory Saul Berlin, MD ’74
George F. Buerger Jr., MD ’62
Don B. Cameron, MD ’60, RESD ’63
Paul J. Corso Jr., MD ’69, RESD ’76,  
BA ’66
Peter L. Crandall, MD ’62
Charles B. Edwards, MD ’64
William H. Ferguson, MD ’53
Nicolae Filipescu, MD ’75, PhD ’64, 
RESD ’78
Frank Elliott Goldberg, MD, RESD ’75
Donald Harter, MD, Professor 
Emeritus of Neurology
Edwin R. Hatch, MD, RESD ’57
Talmage Gordon Hiebert, MD ’62, 
PhD ’56, MA ’54
Ariel Hollinshead Hyun, PhD ’57, 
MA ’55, Professor Emerita of 
Pharmacology
Howard S. Jacobs, MD ’78, BS ’75
Donald R. Johnson, MD ’59
Eloise Kailin, MD ’43, BA ’41
Morris E. Krucoff, MD ’42, BS ’37
Francis K. Mainzer, MD ’59
John Oliver Martin, MD ’55
Donald McKay, MD ’61
Hardin E. Olson, MD ’59, RESD ’61,  
BA ’55
Edgar E. Peltz, MD, RESD ’58
Edward L. Rea, MD ’46, RESD ’51
Annette W. Reda, MD, RESD ’76
Richard B. Rich, MD ’56
Robert P. Saunders, MD ’01
Martin F. Schulman, MD ’76, PhD, 
RESD ’77
Craig Max Seal, MD ’76
Kenneth Seeman, MD ’62
Tracy Lee Silvey, PA/MPH ’02
Jonathan Earl Skillings, PA ’93
Robert L. Strautz, MD, RESD ’75
William T. Thistlethwaite, MD ’87
William Nicholas Toomy, MD ’63
William Jan Van Veen, MD, RESD ’61
Thomas M. Webster, MD ’64
Amy Hise, MD ’96, adjunct assistant 
professor of pathology and interna-
tional health at Case Western Reserve 
School of Medicine, was elected 
to a two-year term on the board of 
directors of the American Medical 
Women’s Association. 
Christine (Cooky) Menias, MD ’95, 
professor of radiology at the Mayo 
Clinic College of Medicine and Science, 
received the American Roentgen Ray 
Society’s 2019 Distinguished Educator 
award at the radiological society’s 
annual meeting in Honolulu, Hawaii, in 
May 2019.
Mary Nordling, MD ’98, BA ’92, 
FAAP, accepted the position of 
program director of the new Tuality 
Family Medicine Residency at Tuality 
Healthcare in Hillsboro, Oregon, where 
she will create the first family medi-
cine residency in Washington County. 
Nordling also received a Bronze Level 
National Program Director Award from 
the Association of Family Medicine 
Residency Directors.
2000s
Raymond Martins, MD ’00, recently 
left Whitman-Walker Health, where 
he served as senior director of clinical 
education and training, to form an 
LGBT-focused medical practice in 
Savannah, Georgia. In addition to his 
role at Whitman-Walker, Martins has 
served as associate clinical professor of 
medicine at SMHS.
Robert Roose, MD/MPH ’05, was 
named chief medical officer at Mercy 
Medical Center, Trinity Health New 
England, in Springfield, Massachusetts. 
Previously, Roose served in the 
regional role of chief of addiction 
medicine and recovery services for 
Trinity Health of New England. 
Shlee Song, MD, RESD ’08, director of 
the stroke center at Cedars-Sinai Medical 
Center in Los Angeles, California, 
presented the keynote address at the 
American University of the Caribbean 
School of Medicine commencement 
ceremonies in Coral Gables, Florida. 
2010s
Simone Bernstein, MD ’19, was recog-
nized in her hometown of St. Louis 
as one of the 2019 St. Louis Women 
of Achievement, in honor of her 
commitment to youth empowerment 
and volunteerism.
Christian J. Rivera, AS ’18, CERT ’17, 
independent duty corpsman with the 
Captain James A. Lovell Federal Health 
Care Center in North Chicago, was 
honored as the Senior Sailor of the Year 
for the Directorate of Fleet Medicine 
(2018–19). 
Timothy Wagner, MD ’13, completed 
the Otto E. Aufranc Fellowship in 
Adult Reconstructive Surgery at New 
England Baptist Hospital, Beth Israel 
Lahey Health, in Boston. 
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2019 SMHS Council of Advisors
Stuart S. Kassan, MD ’72, FACP, MACR, Co-Chair 
Distinguished Clinical Professor of Medicine, 
University of Colorado-Denver School of 
Medicine; Chief Medical Officer, Multispecialty 
Physician Partners
Lara S. Oboler, MD ’95, Co-Chair 
Cardiology; Lenox Hill Heart & Vascular Institute
Christopher L. Barley, MD ’93 
Clinical Assistant Professor of Medicine,  
Cornell/Weill School of Medicine
Constance Urciolo Battle, MD ’67, FAAP 
Pediatrics and Public Health
Carlos R. Diaz, MD ’72, RESD ’75 
President and Owner, Aeromedical Services
Thomas E. Flynn, MD ’86 
Ellsworth Uveitis & Retina Care
Jeanne G. Holzgrefe, MD ’96, PhD, MPH 
Assistant Clinical Professor of Psychiatry and 
Behavioral Sciences, GW SMHS; Chevy Chase 
Psychiatric Services
Jay E. Katzen, MD ’72, BA ’67 
Ophthalmologist, the Eye Center
Kerry L. Kuhn, MD ’73, RESD ’77, BA ’70, FACOG 
Private Practice; Senior Vice President of VitalMD
Gerald S. Lazarus, MD ’63 
Dermatology
John C. Pan, MD ’70, RESD ’74 
Founder, Center for Integrative Medicine,  
GW SMHS
Smita H. Patel, MD, DFAPA 
Assistant Clinical Professor of Psychiatry and 
Behavioral Sciences, GW SMHS
Daniel P. Shepard, MD ’96 
Shepard Eye Center
Art B. Wong, MD ’67 
Founder, Emergency Physicians Medical Group, PC
Dear fellow alumni and friends of GW,
The opportunity to become a physician in the special tradi-
tion unique to GW changed my life. The approach to class 
composition, learning, and the diverse clinical settings in 
which we trained have sustained me with confidence and 
altruism through a nearly 40-year career. To be a physician 
is an incredible privilege, and being in a position to help 
improve the lives of our patients, communities, and society 
is more fulfilling for me than any other endeavor could have afforded. It is with that 
attitude that we need to think about how we can sustain the values and qualities 
of the profession, and support those willing and ready to follow their hearts and 
dreams to become doctors. 
The cost of a medical education is staggering. According to the Association 
of American Medical Colleges, medical students attending private institutions 
carry a mean debt of $209,000. The debt incurred by many can discourage them 
from following their hearts, compromise their idealism, and change their career 
choices. These students need our help. When I think about how to give back, what 
resonates for me are the three familiar words of alumni giving: “learn, earn, and 
return.” The question is, when am I ready to recognize that is a continuum that is 
unique to our profession and deserves to be sustained? It gives us an incredible 
opportunity for ongoing learning, generous income, and giving back in so many 
responsible and important ways through our skills and our means. 
I believe the earlier you embrace the culture of giving back, the greater the 
significance it will have for you. Most of us have found our own individual way, 
it might be through working in a community clinic, going on a medical mission, 
working through organized medicine, or teaching students and residents. But, 
as time goes on, the opportunity and importance of giving financially becomes 
more feasible and more rewarding. There is no better way to do that than to 
contribute to the George Washington University (GW) School of Medicine and 
Health Sciences (SMHS) — the institution that afforded us the chance to become 
the people and professionals we are today. 
In 2011, I was looking for a way to minimize the debt doctors incur through their 
medical education, allowing students to pursue subspecialty training of their 
choosing, without having to take finances into consideration. I also wanted to 
contribute to something that embodied the values of education and service that 
my late mother, Leona Libby Feldman, held dear. I chose to help reduce the burden 
of tuition and to mentor up-and-coming physicians by contributing to the SMHS 
Adopt-a-Doc program. Since then, I have adopted two medical students, and had 
the distinct privilege of hooding them at graduation. This year I’m expanding that 
support to a third medical student and I am even making a commitment to continue 
this for years to come through my estate. Developing professional relationships 
with these students, sharing my perspectives on medicine, and being available as a 
resource has been remarkably gratifying and has allowed me to give back. 
As medical professionals, I hope you will join me in this important role of 
supporting the next generation of GW health care professionals. 
Sincerely,
Russell C. Libby, MD ’79, BS ’74, pediatrician and proud and grateful graduate  
of the Class of 1979
The GW SMHS Council of Advisors offers the dean 
of the School of Medicine and Health Sciences recom-
mendations on strategic priorities and important 
issues for the school, and provides generous support 
and advocacy.
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Bio Banking
The AIDS and Cancer Specimen Resource (ACSR), the largest collection of annotated HIV 
malignancy specimens globally available to researchers, received a $22 million renewal grant from 
the National Institutes of Health. The George Washington University (GW) Biorepository, under the 
direction of Sylvia Silver, DA, professor of microbiology, immunology, and tropical medicine, will 
serve as the primary ACSR site for the next five years. Read more on page 9.
